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 ABSTRACT: THE FACTORS AFFECTING AVAILABILITY OF MEDICINES IN THE 
FREE STATE DISTRICT HEALTH SERVICES  
 
 
The purpose of this study was to identify and explore factors affecting medicine 
availability within the district health services. A qualitative descriptive, exploratory and 
contextual research design was followed. The data collection was conducted through 
two focus group discussions comprising of pharmaceutical managers and district health 
services managers respectively. The study found that medicine was not consistently 
available in the various districts, especially in community health centres and primary 
health clinics. The factors contributing to the non-availability of medicines include 
challenges with deliveries from Medical Depots, poor medicine stock management, 
shortage of pharmacists and pharmacist’s assistants in the facilities, lack of the 
electronic medicine management systems and the separate existence of 
Pharmaceutical Services and Medical Depot within the province. The study made 
recommendations on how to improve medicine availability within the district health 
services. 
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CHAPTER 1 
 
ORIENTATION OF THE STUDY 
 
 
1.1 INTRODUCTION  
 
In 1996, the National Drug Policy (NDP) was developed with the objective of ensuring 
the consistent availability of essential drugs (medicine) to all South African citizens 
(National Department Of Health [NDOH] 1996:3). The NDP is supported by Standard 
Treatment Guidelines and the Essential Medicine List to realise provision of affordable 
essential medicines for each level of care.  Essential medicines are medicines required 
in order to treat the majority of diseases that affect the people of South Africa. Therefore 
it is imperative that medicines be accessible, effective and affordable to the citizens of 
this country.  However, only 10% of Free State Primary Health Care Facilities were 
found to have a full complement of the Essential Medicines  during the last National 
Primary Health Care Survey that was conducted during 2003 (Gavin,Irlam & Levin 
2004:35).  
 
A further objective of the NDP was that of national development, aimed at educating the 
doctors, nurses and allied health professionals on the principles underlying the efficient 
economical and effective procurement, distribution and dispensing of medicine. The 
NDP emphasises that, for the consistent availability of medicinal treatment, there should 
be effective management of medicine; adequate budgeting for said medicine, effective 
stock control and monitoring as well as the availability of adequately trained health 
professionals, capable of issuing medicine to the health services consumers. However, 
in practice there have been several challenges regarding medicine supply.  
 
The inability to provide the required quantity and quality of health care service through 
the availability of essential medicines and consumables were identified as one of the top 
10 strategic risks for the Free State Department of Health (FSDOH). This was due to 
budgetary, supply and logistical failures (FSDOH2010:41). The Free State province’s 
strategic plan of 2010-2014 requires the availability of medicine to be at least an 
average of 95% (FSDOH2010:49). However, in practice the Free State Department of 
  
2 
Health has not been able to maintain this required average level of medicine availability 
(45% during April 2009)(FSDOH 2009:1). As a result the quality of services offered was 
compromised. This, in turn, led to poor health outcomes resulting in patients defaulting 
on their treatment. The resulting situation exposed the Department of Health to various 
negative perceptions within the media (Health24:2010).  
 
1.2 BACKGROUND INFORMATION ABOUT THE RESEARCH PROBLEM  
 
1.2.1 Source of the research problem  
 
During May 2010, South Africa experienced a shortage of over 80 medicinal items in the 
public health sector which included, amongst others, influenza (‘flu) vaccinations and 
medication for hypertension and tuberculosis. The severity of this shortage varied from 
province to province as well as from hospital to hospital within the provinces depending 
on the leadership abilities and skill levels of management (Health24:2010).  
 
In the Free State District Health Services the medicine availability reached an average 
of 45% during April 2009 resulting in patients dying whilst on the waiting list for 
antiretroviral medication (FSDOH 2009:1). Twelve percent of the clients that visited 
Free State District Health Services during March 2010 reported non-availability of 
medication during their visit (Survey Workshop 2010:15). Furthermore, patients with 
chronic conditions including hypertension and diabetes found themselves being without 
their medication or injections for controlling their illnesses. Subsequently, the insufficient 
procurement and distribution of medicines were identified as being amongst the key 
service delivery challenges facing the Department of Health in the Free State (FSDOH 
2010:10). These problems were in contrast with the Health Ten Point plan which 
emphasises the need to ensure sufficient availability of medication at an acceptable 
norm of 95% for essential medicine (FSDOH 2010:49).  
 
According to the Management Science for Health (MSH), investigation the problem 
seemed to be arising from various internal factors rather than external factors and 
needs to be investigated to prevent re-occurrence in the future(MSH 2010:3).  
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1.2.2 Background to the research problem  
 
The availability of medicine is an integral part of the provision of quality health care 
services.  Medicine availability has been regarded as one of the six priorities listed for 
the South African Department of Health (NDOH 2009a:1). In order to improve the health 
profile of all South Africans improving medicine supply and management have been 
identified as key factors in the South African Health Programme of Action (NDOH 
2009b:5).  
 
The Ten Point Plan of the National Department of Health places the emphasis on the 
review of drug policies which may lead to the improvement of medicine availability by 
means of  improved procurement of medicines and the possible establishment of a state 
owned pharmaceutical industry (NDOH 2009b:6).  
 
According to an investigation conducted on the availability of medicines by MSH in 
2009, possible factors which inhibit the availability of medicine in the Free State District 
Health services are as follows.  
 
Firstly, it may be that the Free State Department of Health has failed to fully understand 
and appreciate the fact that medicine is costly, and this that medicine has to be 
managed differently from any other hospital supplies.  
 
Secondly, a dysfunctional and unrealistic organisational structure led to inadequate 
financing and an unreliable, incoherent information management system, which may 
result in patient care suffering the consequences. Management Sciences for Health 
(2010:15) states that the policy making and oversight unit for medicinal policies is 
located in a different directorate than the Medical Depot which is responsible for 
procurement and distribution of medicines to the five districts. This situation has an 
impact on the availability of medicines as the decisions are taken in another unit.  
 
MSH’s investigation further suggests that the positioning of the Medical Depot within the 
finance cluster and it being regarded as a trading entity primarily focusing on financial 
viability rather than on citizen’s accessibility to medicine of adequate quality is a 
challenge.   
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Lastly, the quality and quantity of qualified dispensing professional nurses and 
pharmacists also contributes to the reduced availability of medication, as inconsistent 
ordering was observed in areas with less skilled personnel and high staff shortages. 
 
1.3 RESEARCH PROBLEM 
 
During 2009 the Free State province experienced problems with insufficient medicine 
stock availability in four out of the five districts. This negatively affects the cure and 
treatment of communicable and non-communicable diseases. No formal study has yet 
been conducted in the province to establish the cause of the problem.  
 
With the above mentioned problem the following questions arise: 
 
 Why is there a shortage of medicine in the province? 
 How does this shortage affect patients in the province? 
 
1.4 AIM OF THE STUDY  
 
1.4.1 Research purpose   
 
This study intended to investigate the factors affecting the availability of medicine in the 
various district health services in the Free State.    
 
1.4.2 Research objectives 
 
 Identify the factors affecting the availability of medicine in the various district 
health services in the Free State.  
 Describe the factors affecting the availability of medicine in the various district 
health services in the Free State.  
 Make recommendations on corrective measures to be implemented in order to 
improve the availability of medicine in the various district health services in the 
Free State.  
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1.4.3 Research questions  
 
 What are the factors that contribute towards insufficient availability of medicine in 
the District Health Services in the Free State?  
 How can the Free State Department of Health ensure sufficient medicine 
availability in the District Health Services of the Free State? 
 
1.5 SIGNIFICANCE OF THE STUDY  
 
The study will contribute towards better understanding of factors affecting medicine 
availability and the establishment of a more uniform medicine provisioning system for 
the Free State Department of Health with the intention of improving the overall 
availability of medicine in various health care facilities within all five districts of the Free 
State.  
 
1.6 DEFINITION OF KEY CONCEPTS 
 
1.6.1 Medicine 
 
According to the Merriam-Webster online dictionary (Merriam Webster n.a.), “medicine” 
can be defined as “a substance or preparation used in treating disease”. Furthermore, 
the Medicines and Related Substances Act (Act 101 of 1965, as amended) defines 
medicine as “any substance used in diagnosis, treatment, mitigation, modification or 
prevention of disease”. 
 
For the purpose of this study, medicine refers to those therapeutic substances used in 
the diagnosis, treatment, mitigation, and modification of the majority of the diseases 
affecting the population. These medicines are referred to as essential medicines (World 
Health Organization [WHO] 2011a:2). 
 
1.6.2 Pharmaceutical Service Manager 
 
The definition of this construct can be divided into three lower-level concepts, namely 
pharmaceutical, services and manager which in turn can be defined as follows.  
According to the Oxford Advanced Learner’s Dictionary (2005:1088), pharmaceutical 
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can be defined as connected with making and selling medicines and medicines.  
Service can be defined as a system that provides something that the public needs, 
organised by the government or a private company (Oxford Advanced Learner’s 
Dictionary 2005:1335). Furthermore, manager can be defined as a person in charge of 
running a business or a similar organisation (Oxford Advanced Learner’s Dictionary 
2005:896). For the purpose of this study the Pharmaceutical Service Manager will be 
defined as the person who is in charge of Pharmaceutical Services or medicine 
provision.  
 
1.6.3 District Health Services 
 
Once again, this construct can be divided into three lower-level concepts, namely 
district, health and services. According to the Oxford Advanced Learner’s Dictionary 
(2005:426), district can be defined as an area of a country or town, especially one that 
has particular features, while health can be defined as the state of being physically 
healthy (Oxford Advanced Learner’s Dictionary 2005:690). However, in this case health 
services should be regarded as one concept defined as the work of providing medical 
services. For the purpose of this study, district health services can be defined as the 
health services offered within a demarcated area ranging from primary health care 
services up to district hospital level.  
 
1.6.4 District Managers 
 
Both the lower-level concepts of this construct have been previously defined in the 
above-mentioned paragraphs. However, for the purpose of this study, district managers 
can be defined as managers within either one of the five districts of the Free State in 
charge of the health care services and responsible for health related programmes.  
 
1.6.5 Medical Depot 
 
According to the Oxford Advanced Learner’s Dictionary (2005:916), medical can be 
defined as connected with illnesses and their treatment, while depot can be defined as a 
place where large amounts of goods or equipment are stored (Oxford Advanced 
Learner’s Dictionary 2005:392).  For the purpose of this study Medical Depot will be 
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defined as a provincial store of medicine from which the institutions order medicine and 
other medical consumables.  
 
1.6.6 Strategic Health Programmes 
 
According to the Oxford Advanced Learner’s Dictionary (2005:1461), strategic can be 
defined as something done as part of a plan that is meant to achieve a particular 
purpose or to gain an advantage, while programmes can be defined as an organised 
order of events (Oxford Advanced Learner’s Dictionary 2005:1161). For the purpose of 
this study, strategic health programmes will be defined as the pre-determined 
organisational unit meant to uphold and develop policies for the health care services 
provision within a government department.  
 
1.6.7 Five Health Districts 
 
The five health districts within the Free State include Fezile Dabi, Xhariep, 
Lejweleputswa, Thabo Mofutsanyana and Motheo districts.  
 
1.7 THEORETICAL FOUNDATION OF THE STUDY  
 
1.7.1 Theoretical framework 
 
The framework is defined as an abstract, logical structure of meaning that guides the 
development of the study and enables the researcher to link the findings to the body of 
knowledge (Burns & Grove 2005:37). 
 
For this study a theoretical framework developed and refined by Management Sciences 
for Health in 2011 will be used. This framework guides the provision of the medicines in 
a holistic approach through clearly outlined processes for selection, procurement, 
storage, distribution and usage of medicine. When implemented properly the possibility 
of   ensuring continuous availability of medicine is likely to be successful. The drug 
supply management cycle details the steps required for selection, procurement, 
storage, distribution and usage of medicine.  
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The Drug Supply Management Cycle (see figure 1.1) is a holistic approach to 
medicine supply. The Free State Province Pharmaceutical Services unit adopted the 
principles of the drug management cycle as a basis for its operations.   
 
1.8 RESEARCH DESIGN AND METHOD 
 
1.8.1 Qualitative exploratory, descriptive and contextual design 
 
Qualitative research designs aim for understanding the significance which respondents 
attach to their environment as well as enabling the researcher to change the data 
progressively so that deeper understanding of what is being investigated can be 
achieved (Welman, Kruger & Mitchell 2005:8). This research was conducted through 
experiences of the managers responsible for provision of medicines in the five districts. 
The design used had to provide for in depth narrative and content rich data. It is for this 
reason that the qualitative research design was chosen as it allows for the respondents 
to share first-hand experiences of the subject under investigation to produce best data. 
For this research the best results were obtained by conducting focus groups 
discussions.   
 
There were two focus group discussions held separately for the pharmaceutical service 
managers and the district health managers from the five previously mentioned districts 
within the Free State to provide an in-depth understanding of the problems that are 
faced regarding medicine shortages.  
 
1.8.2 Research method 
 
Wimmer and Dominick (2006:48) indicate that qualitative research involves several 
methods of data collection, such as focus groups, field observation, in-depth interviews 
and case studies. For the purpose of this study the researcher conducted focus groups 
with the pharmaceutical service managers and district managers. Marshall and 
Rossman (2011:93) state that [a]lthough interviewing is often supplemented with other 
data, the primary strategy is to capture the deep meaning of experience in the 
participant’s own words.  
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Figure 1.1 Drug supply management cycle (pharmaceutical medicine 
management framework)  
(Source: MSH 2011:1:10) 
*The italics indicate the responsible unit in the Free State context as at June 2013  
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According to Marshall and Rossman (2011:2), qualitative research is typically enacted 
in a naturalistic setting, focuses on context, is emergent and evolving and is 
fundamentally interpretative. Furthermore, Wimmer and Dominick (2006:116) indicate 
that qualitative research uses a flexible questioning approach.  Although a basic set of 
questions is designed to start the project the researcher can change questions or ask 
follow-up questions at any time.  
 
1.8.3 Focus groups 
 
Focus groups are the qualitative research design method which allows one to obtain in-
depth descriptive data. For the purpose of obtaining as much data and individual 
experiences as possible from the participants’ focus groups the interviews were 
expounded by providing the respondents of both focus groups with a short 
questionnaire to capture demographic details as well as to record responses to certain 
predetermined questions. Wimmer and Dominick (2006:130) refer to this as an 
extended focus group.  
Burns and Grove (2005:542) further state that focus groups are designed to obtain the 
participants’ perceptions in a focused area in a setting that is permissive and non- 
threatening.   
 
There are various advantages to this approach, namely that the researcher can view 
behaviour in a natural setting, excluding the artificiality that sometimes surround 
experimental research. Furthermore, this technique can increase the depth of 
understanding that the researcher may gain from the experience. Finally, this method 
allows flexibility in questioning and clarity regarding information that is collected from the 
respondents (Wimmer & Dominick 2006:49).  
 
The possible disadvantage of the focus group is that some participants are intimidated 
to speak in a group (Welman et al 2005:204). This was overcome by the fact that the 
participants are familiar with each other as they currently work together in the 
department.  
 
A focus group can include 6-12 participants (Burns & Grove 2005:543; Wimmer & 
Dominick 2006:128).In this study there were 12 participants. The two focus groups were 
conducted in Bloemfontein during August 2012.  
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1.8.4 Sample selection  
 
Purposive sampling is used to identify and select the individuals that have more 
information than the regular group members (Welman et al 2005:204). Burn and Grove 
(2005:353) states that purposive sampling involves the conscious selection by the 
researcher of certain subjects to include in the study. The selected subjects are the 
information rich cases from which the researcher can learn a great deal about the 
central focus of the study.  
 
For this study the selected participants were the five districts’ Medical Depot 
Pharmaceutical Manager and one provincial pharmaceutical manager as well as five 
district managers and the Manager Medical Depot.  They were purposely selected as a 
sample on the basis of their experiences and their prominent responsibility in the 
provision of medicine.  
 
The six managers of Pharmaceutical Services were all pharmacists by profession and 
directly responsible for the provision of medicine to the health care facilities as well as 
being the custodians and originators of the reports on medicine availability.  They were 
labelled as Focus Group #1. The second group comprised of the five district health care 
managers and Manager Medical Depot as the key informants responsible for provision 
of health services within the first level of care.  Interestingly they were all professional 
nurses. They were labelled Focus Group #2.  
 
1.8.5 The role of the researcher during focus groups  
 
The researcher observed behind the scenes the interaction and the discussions to be 
able to  take notes and ensure that the research questions are addressed.   
 
1.8.6 The role of the facilitator 
 
To avoid biased results a facilitator for the focus groups was appointed.  The facilitator 
was an experienced researcher who has conducted previous focus groups on a health 
related field. The facilitator’s role was to clarify, paraphrase and reflect back what has 
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been said. The facilitator should remain neutral and non-judgemental (Burns & Grove 
2005:544).  
 
1.8.7 Data collection  
 
Wimmer and Dominick (2006:128) indicate that the focus group is a research strategy 
for understanding audience attitudes and behaviour where no more than 12 people are 
interviewed simultaneously, with a moderator leading the respondents in a relatively 
unstructured discussion about the focal topic.  
 
Marshall and Rossman (2011:145) stipulate that when more than one person 
participates the process takes in a wider variety of information than if there were fewer 
participants as immediate follow-up and clarification is possible. According to Wimmer 
and Dominick (2006:130), focus groups have various advantages including the wealth 
of information that can be gained, the minimal cost of the group and the flexibility in 
question design and follow-up.  
 
1.8.8 Interview guide 
 
Prior to the focus group an interview guide (see Annexure D) was developed in order to 
assist the facilitator of the focus group in collecting the relevant information from the 
respondents. A set of predetermined questions were developed. However, the 
existence of an interview guide does not mean that the moderator (facilitator) cannot 
ask questions not contained in the guide (Wimmer & Dominick 2006:133). The facilitator 
was allowed to ask follow-up questions or probe respondents’ comments during the 
session to gain further insight.  
 
Respondents were asked the central question: “Describe your experiences regarding 
medicine availability, as well as the factors affecting availability of medicine within the 
facilities of the Free State district health services”. The two interviews took place in a 
relaxed environment at a focus group facility in Bloemfontein and was digitally recorded 
for reference purposes as well as for the transcribing of the discussions which is 
essential in the analysis of the data.  
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1.8.9 Data analysis  
 
Data was collected from the transcripts made from the digital recordings and notes that 
were collected during the focus groups. The collected data was organised and analysed 
by means of an inductive model where the data that was relevant to the topic had to be 
grouped into appropriate and meaningful categories. This was enhanced by the use of 
XSight, a software package that was developed for the analysis of qualitative data. 
XSight software assists researchers or other professionals working with non-numerical 
or unstructured data to compile, compare and make sense of their information. It 
provides a range of analysis frameworks for importing, classifying and arranging data; 
tools for testing theories and relationships between items; and the ability to visually map 
and report thoughts and findings (QSRI 2008).  
 
Designed for rapid analysis, XSight can handle small or large volumes of data and 
search and query tools support the review and reflection process and users can look for 
patterns, make comparisons, and interrogate the data in seconds. Explanations usually 
emerge from the data itself.   
 
1.8.10 Trustworthiness 
 
Trustworthiness is the extent to which the study can be regarded as reliable and 
produces credible findings. Lincoln and Guba (1985) suggest that credibility, 
transferability, authenticity and confirmability should be demonstrated in a qualitative 
study (Creswell 2013:246). Trustworthiness and validity of qualitative studies is 
concerned with the truthfulness of the data collected with special emphasis on the 
conveying the insider view and providing the detailed account of how the people we are 
studying understand the phenomenon (Neuman 2011:214). Trustworthiness is about 
the extent to which the study has the potential to produce credible findings and 
interpretation of phenomenon under study.  
 
The test of trustworthiness can thus be described as whether or not the study 
investigates the proposed research questions. All the necessary precautions were taken 
to ensure trustworthiness through identification and selection of appropriate informants 
as well as conducting the research focus group discussion at the facility with an 
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experienced researcher as the facilitator as well as design and refinement of the of the 
interview guide to ensure that the research questions are addressed.  
 
Further strategies to ensure trustworthiness will be presented in more detail in Chapter 
3.  
 
1.8.11 Ethical considerations 
 
The best reason to behave ethically is the personal knowledge that you have acted in a 
morally appropriate way.  Wimmer and Dominick (2006:67) postulate that there are 
other reasons for ethical behaviour, namely that unethical behaviour may have an 
adverse effect on the participants and that unethical research practices reflect poorly on 
the profession. In a clinical environment the researcher will come into contact with 
health professionals and their patients possibly invading their work space which is 
normally managed by authorities. Therefore, the researcher will have to ensure 
compliance with principles of ethical research. Wimmer and Dominick provides general 
ethical principles namely autonomy, which has its roots in the categorical imperative 
and demands the researchers respect towards the rights, values and decisions of other 
people.  
 
The second is nonmaleficience, which is the avoidance of intentional harm to 
respondents, and beneficence, which stipulates that a positive obligation to remove 
existing harms can be identified. Lastly, the principle of justice holds that people who 
are equal in relevant respects should be treated equally (Wimmer & Dominick 2006:69).  
 
The researcher ensured that the study was executed in line with the above ethical 
consideration and obtained clearance from the University and the Free State 
Department of Health to conduct the study (see Annexures A and B).   
 
1.9 SCOPE OF THE STUDY  
 
The study focuses on the factors affecting medicine availability at the first level of health 
care − that is district health services − based on the experiences of Pharmaceutical 
Services managers and district health managers.  
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1.10 STRUCTURE OF THE DISSERTATION 
 
The dissertation is structured into five chapters.  
 
Chapter 1: Orientation of the study  
 
Chapter 2: Literature review 
 
Chapter 3: Research method and design  
 
Chapter 4: Data analysis, presentation and description of research findings  
 
Chapter 5: Study conclusions, summary of findings and recommendations 
 
1.11 CONCLUSION 
 
Conducting research on factors affecting availability of medicine in the district health 
services facilities would be beneficial to the researcher, the employer as well as the 
community of the Free State in that the research outcome might be an indication of 
what factors need to be considered in ensuring consistent availability of medicines in 
the district of health services which is essential for treatment and management of 
diseases and increase the life expectancy of the population.  
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CHAPTER 2 
 
LITERATURE REVIEW 
 
 
2.1 INTRODUCTION  
 
This chapter explores and describes the current situation in the different parts of the 
world in terms of the availability of medicines and the factors affecting the availability 
thereof.   
 
The provision of health services across the world is associated with medicine 
prescription and issuing to patients and clients accessing health facilities. It is therefore 
essential that a constant pharmaceutical (medicine) supply is ensured to promote 
effective care, inspire confidence in the health facilities and contribute to job satisfaction 
and self-esteem amongst staff (MSH2011:1:4).  
 
It has been established that the quality of a public health care system is evaluated by 
the patients on the basis of appropriate medical staff members and availability of 
needed quality medicines (MSH 2011:1:3). Medicine has special importance for at least 
five reasons, namely:  
 
 It aids in saving lives. 
 It helps promote trust and participation in health services. 
 It is costly. 
 It is different from other consumer products. 
 That substantive improvement in the supply and availability of medicines is 
possible. 
 
Over the years household and patient surveys around the world have found that 
medicine availability is a major determinant of where patients go for health care and 
how satisfied they are with said care. In addition to the direct effect on health, the 
availability of essential medicines attracts patients who can then also receive preventive 
and public health messages (MSH 2011:1:4). It can therefore be concluded that the 
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inability of the health services to provide medicines on time and in the right quantities 
has the potential to cause the public to lose confidence in the health care system, 
resulting in the decrease of patient numbers and increase in avoidable morbidity and 
mortality amongst the health service users.   
 
The Declaration of Alma-Ata in 1978 − a milestone in international public health − was 
the first official document to underline the importance of primary care and the role of 
essential medicines at a global level. It is a worldwide reality that medicine accounts for 
15% to 30% of health spending in transitional economies and 25% to 66% in developing 
countries.  
 
In some developing countries, medicine is the largest health expense for poor 
households. The projections are that by 2015 over 10 million deaths per year could be 
avoided by scaling up certain health interventions, the majority of which depend on 
availability of essential medicines (WHO 2011a:2).  
 
The United Nations identified access (and availability) to essential medicines in 
developing countries as one of the indicators of the Millennium Development Goal Eight 
focusing on developing global partnership.  Development and medicine availability is 
considered fundamental to guarantee adequate healthcare and safeguard human rights 
(United Nations [UN] 2011:51). Medicine therefore needs to be accessible to the 
population in acceptable quantities, dosages and quality, and at affordable prices.   
 
In an investigation  conducted on the  availability of 15 generic medicines in 36 
developing countries Cameroon, Roubos, Ewen, Teeuwisse, Leufkens and Laing 
(2011:412) discovered that, unfortunately, low medicine availability is prevalent in low 
and middle income countries.  Several studies reported that the availability was at an 
average of 38%. Further, according to the United Nations Report, the prevailing limited 
availability of essential medicines in the public sector is often caused by factors 
including lack of resources, under-budgeting, inaccurate demand forecasting or 
inefficient procurement and distribution. The non-availability of medicines in the public 
sector has a negative impact of forcing patients to buy medicine from private providers, 
which often charge two to three times more. The affordability is further compromised by 
the private sector’s preference for originator brand products which further increases the 
price and makes treatment even more unaffordable. Prices in the private sector tend to 
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also be higher due to higher manufacturers’ prices, taxes and tariffs, and high mark-ups 
in the supply chain (UN 2011:51).  
 
2.2 INTERNATIONAL CONTEXT AND STRUCTURES PROMOTIONG PROVISION 
AND AVAILABILITY OF ADEQUATE MEDICINES 
 
Medicine availability and prices in both public and private sectors are the key global 
indicators of access to treatment and health services. For the effective global 
coordination of medicine programmes as key component of health service delivery, a 
Department of Essential Medicines was established in the WHO structure.  The WHO 
recognises the importance of strengthening provision and availability of medicines 
worldwide. It further established a presence in all regional offices and branches of the 
Department of Essential Medicines Programme for the coordination of initiatives 
towards promotion of access to medicine efforts and revision of pharmaceutical policies 
in member countries, to give input into the world’s efforts of ensuring access and 
availability of medicines in sufficient quantities and quality across various states (WHO 
2011a:2).  
 
This department, through the work in the branches across the regions, lobby for design 
as well as the review of medicinal policies and production processes, including the 
development of generic medicines that are cost effective and affordable compared to 
the original brands.  
 
Based on the work done in the member countries the Department of Essential 
Medicines publishes the annual reports on the medicine situation in the world to share 
progress and challenges towards increasing access and availability of medicine 
worldwide. The published reports recommend that governments should determine the 
essential medicines list for their own countries to serve as a guideline as to which 
medicine is required for continuous availability to manage prevailing health conditions. 
Following these recommendations there have been various initiatives across the world 
to promote access to essential medicines, including development of country specific 
medicine policies.  Furthermore it prompted review of drug and medicinal policies to 
enable other health worker categories, in addition to the medical doctors, to prescribe 
medicine in areas with inadequate availability of doctors.  There are also on-going high 
level negotiations through the WHO Heads of States forum for shift towards use of 
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generic medicines instead of original brands in order to reduce the prices of medicines 
to ensure availability of essential medicines in all parts of the world, especially 
developing countries, including South Africa (MSH 2011:1:10).   
 
2.3 KEY PROCESSES FOR ENSURING EFFECTIVE MEDICINE SUPPLY 
MANAGEMENT  
 
Management Sciences for Health developed a framework which has been adopted by 
the WHO to serve as a guide and mechanism to ensure adequate provision of medicine 
by following the key processes of selection, procurement, distribution, and use. At the 
centre of these processes, management support is key. These processes make up what 
is referred to as the Drug Supply Management Cycle.  This is a holistic approach to 
medicine supply management and cannot be executed in isolation, but should be well 
aligned and executed comprehensively for optimum results (MSH 2011:1:10).   
 
Globally, Pharmaceutical Services (units responsible for facilitating acquisition of 
medicines for the health sector) adopted the principles of the drug management cycle 
as a basis for their operations. When the cycle is implemented properly the possibility of 
ensuring continuous availability of medicines is likely to be successful. The aim of the 
cycle is to ensure the availability of cost effective, safe and quality essential medicines 
to the communities as governed by the National Medicine Policies (NMP) and 
supporting legislation.  
 
Inadequate implementation of the key processes in this cycle will lead to a lack of 
coherence and eventual collapse of the structure and the services, resulting in delay or 
even non-provision of the medicine to the facilities. Although the individual parts of the 
cycle may function independently for a while, the cycle as a whole will soon collapse 
when the elements are separated.  Patient care will suffer without a functional 
organisational structure, adequate financing, reliable information management and 
motivated staff (MSH 2011:1:9).   
 
2.4 CONCEPT OF MEDICINE AVAILABILITY  
 
The South African Concise Oxford Dictionary (2007:273) defines medicine as a drug or 
preparation used for the treatment or prevention of disease. In South Africa, in 
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accordance with the Medicine and Related Substances Act (Act 101 of 1965, as 
amended), the term medicine refers to any therapeutic substance or mixture of 
substances used or purporting to be suitable for use or manufactured or sold for use in 
the diagnosis, treatment, mitigation, modification or prevention of disease, abnormal 
physical, mental state or the symptoms thereof in man or restoring, correcting or 
modifying any somatic or psychic or organic function in man (South Africa 2002:3).  
 
It is important to note that various medicines are continuously being introduced into the 
market by manufacturers.  However, not all medicines are necessary for human life 
preservation and, as such, not all medicines are useful to the health system.  The World 
Health Organisation defines medicine with a special focus on medicines required to 
treat the majority of the priority health conditions, referred to as essential medicines, 
which should be available at all times.  Essential medicines are defined as those 
medicines that satisfy the priority healthcare needs of the population. These medicines 
include first line treatment for chronic non-communicable conditions, communicable 
disease, vaccines, HIV and AIDS. These therapeutic substances are said to be 
available when the stock on hand is able to ensure that the patients receive all the 
essential  prescribed items on the day of the visit to the health facilities (WHO 2011 
a:2).  
 
To ensure human safety, the governments of different countries, in line with WHO 
standards, have introduced regulations for the production, distribution and prescription 
of carefully selected medicines as well as strived to ensure continuous availability of 
essential medicines. The rationale for the selection and use of a limited number of 
medicines is that it leads to an improved supply of medicines, more rational prescribing, 
and lower costs (MSH 2011:16:3).  
 
2.5 GLOBAL SITUATION OF MEDICINE AVAILABILITY  
 
The 2011 WHO report is based on the standard methodology and focuses on essential 
medicines used in the majority of the member countries.  The report indicates that 
medicine availability across the WHO regions was reported at an average of 60%. In the 
Eastern Mediterranean region medicine availability scored 32%, with 58% in the 
European region.  In the African and South Asian regions the average availability was 
less than 60% (WHO 2011a:4).  
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A study conducted in 36 countries reports that in the public sector the availability of 15 
generic medicines was found to be low, ranging from 9,7% in Yemen to 79,2% in 
Mongolia.  
 
The regional availability ranged from 29,4% in Africa and 54,4% in America. In the 
private sector the availability of generic medicine was lower, ranging from 50,1% in the 
Western Pacific to 75,1% in South East Asia. The lowest availability of medication was 
recorded in Chad to be at 14,8%, Kuwait 36,3%, Philippines 33,6% and China ranging 
from 34,6% to 38,3%. The mean availability of medicines was found to be generally 
lower in the public sector than in the private sector. The factors contributing to low 
availability of medicines in the public sector in particular include inadequate funding, 
lack of incentives to maintain stocks, inability to forecast accurately, inefficient 
distribution systems or leakage of medicine for private use.  In the private sector the 
factors influencing availability and access was mainly the price.  However, the private 
sector shows a high availability of generic medicines in the private sector, such as 
recorded in Syria at 97,5% and in Chenai, India, of 91,8%.  Factors contributing to this 
were setting of limits on the price mark-up and elimination of taxes on medicinal 
products (Cameron et al 2008:8).  
 
While the availability of generic essential medicines is limited in general, especially in 
the public sector, the situation with regard to medicine for treating chronic conditions is 
particularly poor. This is very disturbing given the fact that chronic diseases are the 
cause of no less than 40% of all deaths in low income countries. The MDG Gap Task 
Force 2010 report reflects that generic medicines used for chronic conditions are 
available in only 36% of the facilities in the public sector and 55% of those in the private 
sector. Moreover, only 27% of respondents from poor households in low-income 
countries who needed treatment for a chronic condition reported having received it (UN 
2011:52).  
 
Gray and Manasse (2012:158) in recent commentary in a Belgian pharmacy journal 
claims that the problem is global − "from Afghanistan to Zimbabwe" − listing 21 
countries affected by a variety of medicine supply problems.  
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A shortage of the injectable antibiotic Streptomycin was reported in 15 countries in 
2010, with 11 more countries predicting their stocks would run out before they could be 
replenished.  This report states that there was a wide range of causes for medicine 
supply shortages, some of which could be dealt with by government agencies.  
 
Due to low medicine availability in the public health sector patients from lower income 
countries, including South Africa, are forced to buy medicine privately, where original 
brands are sold costing the public a possible four times the price of the generic 
medicines (WHO 2011b:7). The non-availability of medicines in public health facilities 
and high cost of original brands result in patients from poor lower income countries 
being exposed to the risk of defaulting treatment and disease complications, which 
contributes to reduced life expectancy as well as premature mortality and morbidity.  
 
Medicine is a critical commodity for maintaining the health status of citizens across the 
world.  It should be free at a point of service for poor communities and accessible to all 
countries at affordable prices. However, according to Mercurio (2007:23) the availability 
of medicine is also affected by inflated medicine prices due to tariffs levied by the 
production countries on medicine leaving their shores. In the Democratic Republic of 
Congo the tax levied on medicine is 30%. Other countries, including India, Sierra Leone, 
Nigeria and Bolivia, also impose tariffs on the importation of pharmaceuticals, namely 
55%,40%, 34% and 32% respectively. The charging of additional sales tax in countries 
including South Africa (14%), Argentina (21%), Bangladesh (15%), The Dominican 
Republic (28%), Greece (15%) and Turkey (18%) is another factor affecting medicine 
availability and access to medicine by individual patients.  
 
The WHO made the following recommendations to facilitate lifesaving medicine’s 
availability and access: improve financing and distribution efficiency, promote the use of 
generic products and control supply chain costs by limiting the mark-ups and remove 
duties and taxes on medicine. It is believed that improvement in the availability of 
medicine through these measures will contribute towards achievement of Millennium 
Development Goals 4, 5 and 6 which lobbies for reduction of infant mortality, improving 
maternal health and combating HIV and AIDS, tuberculosis and malaria (WHO 
2011a:2).The WHO further proposes a review of policies towards improving the 
availability of medicines, including the components of medicine selection, procurement, 
distribution, and financing. Financing models include promotion of the provision of free 
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essential medicines and also the introduction of the insurance system, like medical aid 
and subsidies, for different categories of the population (WHO 2011 b:13).  
 
Management Science for Health strongly advocates the promotion of equitable access 
to quality medicine as both a key development challenge and an essential component of 
strengthening the health systems and primary health care reform in the world.   
 
For the provision and continuous availability of medicines it is regarded to be an 
important priority that countries design and implement the National Medicine Policy to 
guide selection, procurement, distribution, and use of medicine. The National Medicine 
Policy is regarded  as an indication for political commitment and a guide for action that 
demonstrate how the government will ensure that efficacious and safe medicine of good 
quality are affordable, accessible, available, and rationally used (MSH 2011:1:9).  The 
majority of WHO member countries, including South Africa, have approved national 
medicine policies.  
 
2.6 OVERSEAS COUNTRIES MEDICINE AVAILABILITY CONTEXT  
 
2.6.1 United States of America 
 
Whilst USA is regarded as a developed country, it is also affected by the non-availability 
of medicine. Gray and Manasse (2012:158) report that shortages of essential 
medicines, amongst them generic injectable chemotherapy agents, are an increasing 
cause for concern in the country (USA). The problem is said to be far greater, affecting 
other classes of medicines including injectable anaesthetic agents, nutrition and 
electrolyte products, enzyme replacement products and radio pharmaceuticals.  Further, 
Erin Fox, Manager of the drug information centre at the University of Utah, states that 
the reported drug shortages are at its highest in a decade in the United States of 
America. The service is said to have recorded 211 new drug shortages, up from 70 
shortages in 2006 and 166 in 2008. The shortages have an impact on patient safety and 
care standards with more than 1000 near misses and adverse patient outcomes 
reported (Larkin 2011:28). The lack of some of the most basic medications has caused 
physicians to advise their patients to seek the medicines they need from locations 
outside the United States of America.  Manufacturing quality problems have been 
implicated as one of the contributing factors in shortages of medicines produced by a 
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limited number of suppliers, such as the influenza vaccine. Overall 43 % of 127 
shortages investigated by the United States Food and Drug Administration were 
attributed to manufacturing quality problems (Nash 2012:12). The other factors 
contributing to the non-availability of medicines in the United States of America include 
medicine manufacturers depending on a small number of facilities for medicine 
production, and that shut-downs for various reasons may cause problems. Changes in 
procurement practices are also another factor (such as insistence on the WHO 
prequalification status or registration with a stringent regulatory authority) which may 
invalidate a previous supplier as in the case of Streptomycin (Gray & Manasse 
2012:158).  
 
2.6.2 Mexico 
 
According to Wirtz, Russo and Escoban (2009:30) in Mexico, like many other 
developing countries, access to and availability of medicines has been hampered by 
various factors, including stock outs in the public health sector (especially for the 
uninsured population) as well as the out of pocket expenditure on medicines and the 
fragmentation of the Mexican health system.  Access to and availability of medicine was 
further limited by the fact that at least 42% of the health services users had to pay for 
their prescribed medicines.  Thus, if the patient could not pay he will not obtain the 
required medicine. Over the years population access does not seem to have improved 
significantly as the patients who had to buy medicines in private pharmacies increased 
from 42% in 2000 to 47% in 2006.  
 
2.6.3 China 
 
Yang, Dib, Zhu, Gang and Zhang (2010:224) reported that in the availability of low price 
generic medicine in the Hubei province was found to be 38,9% in the public sector and 
44,4% in the private sector. The factor reported to contribute mainly to the low 
availability of generic medicines in the public sector was that doctors did not prescribe 
medicines on the essential lists resulting in essential medicines not being ordered for 
utilisation in public health facilities. Another survey conducted in 2006 in Shanghai, 
China, revealed that the overall availability of medicine was poor in both the public and 
private sectors.  Generic medicine was more readily available in the public sector than 
the private sector. The average availability in the public sector was 13,3% for the 
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innovator (non-generic expensive) brand and 33,3% for the lower priced generics 
respectively, whilst in private pharmacies the average availability for innovator brands 
was 10% and 15 % for lower priced generics. The factors contributing to low availability 
were: 
 
 Poor quality of medicine in circulation, as the strength of medicine available 
differed from the recommended strength in the WHO survey manual. 
 Lack of supply from the manufacturers due to low government prices. 
 Irrational use of medicine due to financial incentives. 
 That profit driven prescribing physicians were prescribing more expensive 
medicines. 
 The issuing of hospicentric medicine which led to low medicine availability in 
private pharmacies as patients were encouraged to obtain medication in hospital 
rather than in private pharmacies; and 
 That the policy on global budget control on pharmaceutical expenditure limited 
the procurement of innovator non-generic medicines (Lu Ye 2006:35).  
 
2.6.4 India 
 
Kotwani, Ewen, Dey, Iyer, Lakshmi, Patel, Raman, Singhai, Thawani, Tripathi and Laing 
(2007:645-654), in a study conducted in six sites in India, found that the average 
availability of core medicines in accordance with WHO methodology was low ranging 
between 30% in Chennai ,10% in Haryana, and 12,5 %in Kartnataka. The factors 
contributing the low availability included poor consideration and disregard of the state 
essential medicine list in the prescription patterns by the clinicians, limited finances for 
medicine, inefficient distribution systems and utilisation of different essential medicine 
lists by pharmacies leading non-availability of medicines prescribed by specialists.  
 
Patel, Thawani and Gharpure (2005:10) recommend the following strategies to improve 
medicine availability: 
 
 That India should legalise implementation of one country essential medicine lists 
to reduce the number of available medicine in the country; 
  
26 
 That the usage of generic medicines rather than the non-generic brands should 
be promoted; 
 That pharmacists should be empowered to issue generic brand equivalents; and 
 The introduction of national regulation of medicinal prices.  
 
2.6.5 Malaysia 
 
According to Babar, Ibrahim, Sing and Bukhari (2005:17), in the Malaysian public sector 
only 25% of the generic medicines were available in the 20 facilities surveyed. The 
factors contributing to the low availability were under-regulation of medicine prices, 
uncapped mark-ups by health practitioners and poor monitoring for the provision and 
procurement of medicines on the National Essential Drug List. The pharmacist’s role in 
ensuring the availability of medicine was also limited as medicine was freely available in 
private doctors’ consulting rooms.  However, stricter measures were imposed on 
medicine control and issuing by pharmacists. The country also did not have a national 
medicine pricing policy. The recommendations included that government should control 
mark-ups on generic brands and ensure that medicines on the National Essential Drug 
List are available in the public sector.  
 
2.6.6 Philippines 
 
A 2009 study conducted in the country using WHO methodology indicated that 
availability of essential medicines in the public health facilities was 53,3%. In the private 
sector it was at 100%, and in central district warehouses supplying the public sector it 
was 33,3%.  The stock out duration for the public facilities was an average of 24,9 days 
and 43,8 days in the central districts warehouses respectively. The factors contributing 
to the low availability were non-centralisation of procurement from the district 
warehouses, as facilities could still bypass the warehouses to obtain medicines 
elsewhere, as well as high medicine prices in the country (Batangan & Juban 2009:34).  
 
2.6.7 Summary of common factors affecting medicine availability in overseas 
countries 
 
The common factors identified were pricing, tax levies, use of  expensive non-generic 
brands, unsubsidised medicine in state facilities resulting in out of pocket expenses, 
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poor quality of medicines not compliant with WHO standards, and irrational prescribing 
by health professionals. 
 
2.7 AFRICAN COUNTRIES’ MEDICINE AVAILABILITY  CONTEXT  
 
Over the years the African region has also experienced an alarming lack of essential 
medicines in the public sector, driving patients to pay higher prices in the private sector 
or stay without medicine to manage their ailments and diseases. In an attempt to turn 
around the situation, the African Region of WHO hosted a consultative workshop to 
explore ways to improve access to and availability of medicine.  During this workshop 
the major contributing factor to medicine shortages was identified as African countries 
having weak or no mechanisms for essential medicine availability monitoring and 
evaluation (WHOAFRICA 2006:38).  
 
In subsequent developments on the continent the Southern African Development 
Community (SADC) regarded improvement in the availability of medicines in Africa as a 
key development priority to the extent of adopting a SADC Pharmaceutical Business 
Plan for the period of 2007 to 2013.  
 
The main objective is to improve sustainable availability of and access to affordable, 
quality, safe and effective essential medicines through regulation and facilitation of trade 
within SADC region, as well as harmonising standard treatment guidelines and essential 
medicine lists (SADC Secretariat 2007:4).  
 
The input from the partners was that the public sector is suffering stock out of medicines 
because of the poor planning, low consumption, and estimates which deplete the 
medicine reserves from the suppliers. Warehouses stock levels are kept based on what 
is expected to be consumed to minimise medicine overstock and expiry of medicines in 
the manufacturers’ warehouses (WHOAFRICA 2006:13).  
 
As will be made clear in the following paragraphs the consistent availability of essential 
medicine in the continent is far from being achieved.   
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2.7.1 Ethiopia 
 
In a study conducted by Daniel, Tegegnenwork, Demissie and Reithinger (2011:61) 
provision of continuous access to essential medicines, laboratory services and medical 
supplies is regarded as fundamental in addressing the health needs of the population.  
However, in 10 out of 48 (21% of) facilities that were surveyed no malaria, tuberculosis 
or HIV medicines were available. The shortage of human resources and weak supply 
chain processes were reported as the main factors contributing to the non-availability of 
medicines in this country.  
 
2.7.2 Malawi 
 
Lufesi, Andrew and Aursnes (2007:86) found that medicine necessary for treating 
pneumonia, malaria and sexually transmitted infections were out of stock for a period of 
42 to 240 days per year. The main factors reported for these shortages were poor 
deliveries from the Regional Medical Store, poor medicine stock management practices, 
delays in the ordering of medicine, as well as lack of training and supervision in the 
facilities and medical stores. The authors recommend that logistical systems should be 
put in place to ensure continuous medicine availability.   
 
2.7.3 Kenya 
 
A 2008 study by Kangwana, Njogu, Wasunna, Kedenge, Memusi, Goodman, Zurovac 
and Snow (2009:737) investigates the availability of malaria medication in government 
facilities. The study shows that 25, 6% of the surveyed facilities did not have any of the 
four treatment packs in stock. The factors contributing to this stock out are mainly 
procurement failures and delays due to a shift made away from direct procurement 
towards open tender processes.  This shift was intended to achieve value for money 
and increase competition amongst potential suppliers. The open tender system 
implementation was further delayed by difficulty to obtain compliant tender bids from the 
bidders. The recommendation from the study was that procurement processes should 
be strengthened and impact: cost analyses conducted  before deciding on international 
open tenders as the processes can be of extended duration leading to medicine stock 
outs.  
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2.7.4 Uganda  
 
A review of drug management and procurement practices conducted in the period 2006 
to 2007 at the Kilembe Hospital in the Kasese District revealed that there were frequent 
medicine stock outs in the health units ranging between 24 and 94 days on average. In 
addition, large quantities of expired medicine were found in most district level facilities. 
The factors contributing to this situation were the irrational procurement and provision of 
medicines not based on needs and requisition, and poor quantification and donor driven 
supplies without proper coordination with the recipient department to determine actual 
need. These practices led to the non-availability of essential medicines required for the 
treatment of prevailing conditions in the country (Tumwine, Kutyabami, Odoi & Kalyango 
2010:559).  
 
2.7.5 Sudan 
 
The availability of essential medicines in this country is relatively higher with medical 
stores and private pharmacies reporting the average availability at 100%, and 82% in 
public facilities.  
 
The high availability is enhanced by the existence of a central medicines store which is 
a governmental corporation responsible for ensuring that quality medicines are available 
at affordable prices through, amongst other strategies, the creation of dedicated funding 
for medicine, and the implementation of good procurement, storage, transportation and 
distribution practices.  Areas reporting lower medicine availability report contributing 
factors as being the absence of drug (medicine) inventory cards, and poor financial 
support for transportation and distribution from the central medicine store to the 
pharmacies (Elamin, Ibrahim & Yousif  2010:36).  
 
2.7.6 Nigeria 
 
This country also faces the challenge of low- and non-availability of medicine as 
evidenced by the health centres and primary health care centres reporting stock out of 
essential medicines. The factors cited for these stock outs include inadequate 
budgetary allocations for medicines, poor stock control in supply chain processes, poor 
quality medicine not containing the minimum required ingredients for effectiveness, poor 
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value for money, uncoordinated government action and local non-availability of quality 
essential medicines. The country has developed a Ten Remedies Plan to improve 
availability, including establishing a dedicated fund for Primary Health Care, direct 
procurement of medicines, and utilisation of a drug supply management cycle in the 
medicine management processes (Ohuabunnwa 2008:12).  
 
2.7.7 Summary of common factors affecting medicine availability in the African 
Region 
 
The unregulated pricing of medicines, donor driven availability of medicines with poor 
coordination with the recipient department, poor warehousing practices ,lack of skills in 
quantification and medicine supply management, and shortage of skilled human 
resources to manage medicine stock.  
 
2.8 THE REPUBLIC OF SOUTH AFRICA’S NATIONAL CONTEXT OF MEDICINE 
AVAILABILITY  
 
Prior to the implementation of South Africa’s democratic government, dispensation 
medicine policies were also in line with the fragmented provision of the health services 
model.  This resulted in differentiated access and varied availability of medicines due to 
lack of standardised essential medicine lists. In 1996 the National Drug Policy (NDP) 
was developed and approved by the new government in line with WHO standard 
requirements of member countries developing and implementing national medicine 
policies. The primary objective for the NDP was that of ensuring the availability of 
essential medicines (medication) to all South African citizens. The NDP is supported by 
Standard Treatment Guidelines and the Essential Medicine List for each level of care to 
realise the provision of affordable essential medicines (South Africa 1996:3).  
 
The NDP defines Essential medicines as those medicines that are required to treat the 
majority of diseases that affect the people of South Africa in line with the WHO’s 
accepted definition. Therefore it became imperative that such medicines are accessible, 
effective and affordable to the citizens of this country. The government is expected to 
ensure availability of generic essential medicine through implementation of incentives 
that favour generic medicines and their production in the country (South Africa 
1996:10).  
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A further objective of the NDP is that of national development aiming at educating 
medical doctors, nurses and allied health professionals on the principles underlying the 
efficient, economical, effective procurement, distribution and dispensing of medicines.  
 
The NDP emphasises that, for the consistent availability of medicinal treatment, there 
should be effective management of medicine; adequate budgeting for medicine, 
effective stock control and monitoring as well as the availability of adequately trained 
health professionals capable of issuing medicine to the health services consumers 
(South Africa 1996:28). In this country the major platform through which citizens’ access 
basic health services and medicines has been identified as primary healthcare centres 
which are located within the district health services. The provision of medicines in the 
primary health care context has been free for all citizens since 1994 in an attempt to 
promote healthy living and improve life expectancy of the population (South Africa 
1997). Although the medicine policies are in place, medicine availability has not been at 
an acceptable, consistent average.  
 
During May 2010 South Africa experienced a shortage of over 80medicines in the public 
health sector which included, amongst others, influenza vaccinations, medication for 
hypertension and tuberculosis.  
 
The severity of this shortage varied from province to province, as well as from hospital 
to hospital within the provinces, depending on the leadership abilities and skills levels of 
management (Health24:2010).  
 
The Public Service Commission results of the 2010 Citizen Survey also indicated that 
there were instances where citizens visited service delivery points and returned without 
receiving what they needed.  Of the patient (10,5%) who participated in the survey were 
told to come the following day for their treatment, due to lack of sufficient stock of 
medicine or that it was time for staff to knock off for the day (Public Service Commission 
2011:41).  
 
As the challenges with the health services provision, including medicine availability, 
continued to surface the need to strengthen District Health Services to become well-
functioning was also identified as a core principle of Primary Health Care Re-
engineering processes (Gray, Vawda & Jack 2011:23). The re-engineering process, it is 
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believed, will contribute towards the efficiency of district health services in the rendering 
of required essential services and will ensure that health programmes are available.  
This will include the provision of medicines, as well as treatment and care to the 
population in the areas where they live. The National Department of Health formally 
recognised that medicine availability is cardinal in the provision of quality health care 
services to the extent where medicine availability has been regarded as one of the six 
Ministerial priorities required for compliance in all public health facilities (NDOH 
2011a:16).  
 
In further developments over the years the South African Government has also 
regarded Health as one of 12 key outcomes to be prioritised during the 2009-2014 
government term of office towards ensuring a better life for all South Africans and the 
achievement of the Millennium Development Goals during the period 2010-2015(GCIS 
2010). In order to improve the health profile of all South Africans improved medicine 
supply and management have been identified as key factors in the South African Health 
Programme of Action.  
 
The National Department of Health’s (NDOH) Ten Point Plan emphasises the review of 
drug policies which may lead to the improvement of medicine availability by means of 
the improved procurement of medicines and the possible establishment of a state 
owned pharmaceutical industry (NDOH 2009b:5). In its Medium Term Review 2009-
2014 of progress towards achievement of the Ten Point Plan the NDOH reported 
access to medicine as an achievement for the country due to reduced medicine prices 
because of generic medicine and bulk purchasing power. A major reduction in the 
prices of ARV medicines was the main output.   
 
In 2010/11, the NDOH awarded a tender to the value of R4. 2 billion over two years for 
the procurement of antiretroviral (ARVs). The Department amended the usual 
procurement strategies which resulted in a saving of 53% (R4. 4billion) on ARV 
medicines. Further reductions were achieved in TB medicines and antibiotics.   
 
The benefit of this watershed event for South Africans is that these savings will enable 
the health sector to treat more patients with the same resource envelope (NDOH 
2011b:35). However, this achievement has been impacted negatively by media reports 
of continuing medicine stock outs.  This is especially true of AIDS medicines in at least 
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six provinces including KwaZulu-Natal, the Free State, Gauteng and Limpopo during 
2012 (South African Press Association 2012). The negative media coverage on the non-
availability and stock out of medicines ensured the public health services a poor 
reputation as service users did not receive the expected medications as they visited 
health facilities (Thom & Langa 2010:7).  
 
A study conducted on Pharmaceutical Management of Tuberculosis in seven of our nine 
provinces found that the availability of ARV and TB medication was at less than 95 % in 
five of the provinces, namely the Free State, Eastern Cape, Gauteng, Limpopo, and 
Mpumalanga. The factors contributing to this low availability, especially in clinic settings, 
include poor stock control and management in nurse-led primary health clinics, and a 
lack of pharmacist’s assistants to take charge of drug supply management. A lack of 
electronic stock management systems also play a role as manual stock cards were 
found not to be updated at most facilities (Pure Health Consulting 2012:97). 
 
Western Cape and North West had above 95% availability. The factors that contributed 
to this include electronic stock management, maintenance of the 3 month buffer stock, 
close monitoring and weekly reporting on stock availability, active contract  
management, and interaction with the suppliers over quantification, shortages and 
forecasting of needs, involvement of all role-players in medicine stock management 
including finance, programme managers and pharmacists and adjustment  of issuing 
quantities during limited stock period to ensure that all patients receive medication 
whilst waiting for the replenishment stock (Pure Health Consulting 2012:129). 
 
In response to the continuous challenge of poor health services and dissatisfaction 
including medicine stock outs, long waiting times, cleanliness, and staff attitudes across 
the country, the Ministry of Health called for a review of the Health Act to make 
provision for the establishment of the Office of Health Standards Compliance. The 
function of the Office is, amongst others, to develop National Health Standards with 
which all health facilities will have to comply for provision of quality healthcare services 
(Gray et al).These standards have been developed and include the standard for the 
availability of medicine as a vital measure of quality and is a priority area. 
 
In 2011 the Ministry of Health commissioned a baseline audit for all public health 
facilities based on these standards. The purpose was to assess the current state of 
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health services as well as the degree of compliance with standards. The results showed 
that the majority of health facilities did not comply with medicine availability standards 
due to stock out of essential medicines (Gray et al 2011:62).  
 
In 2012 the Ministry of Health, responding to the countrywide medicine shortages, 
adopted what is called non-negotiables for the public health sectors. The non-
negotiables list is a list of items that are supposed to be available at all times for the 
continued provision of safe and quality health services. These items include medicine, 
cleaning materials, as well as equipment and laboratory services. The Minister called for 
provinces to do sufficient budgeting and ring-fence these funds with the intention to 
minimise the recurrence of non-availability of essential goods and services for basic 
service delivery (NDOH 2012a:1).  
 
Whilst turnaround strategies are being implemented, the insufficient availability of 
pharmacy personnel in the public health system is said to be amongst the contributing 
factors in the non-availability of medicine in district health services as nursing personnel 
tend to prioritise the service delivery and lag behind with consistent ordering of 
replacement medicine stock as well as following up on placed orders for uninterrupted 
supply and availability of medicine (Strengthening Pharmaceutical Services 2008:29). 
 
For quality and efficient medicine provision the South African Pharmacy Council 
advocates the availability of pharmacists and pharmacist’s assistants to take charge of 
the provision of medicines in the hospitals, community health centres and primary 
health clinics in an environment compliant with Good Pharmacy Practice (South African 
Pharmacy Council 2010:2). However, in practice there have been several challenges 
regarding availability of pharmacists and pharmacists’ assistants in public health 
facilities with hospitals and Community Health Centres not having permanent 
pharmacists. In primary health clinics nurses are in the main the only available 
personnel responsible for the provision-, ordering-, control of and enabling access to 
medicines (International Council of Nurses 2011). 
 
This situation has the potential for the consistent non-replenishment of medicine stock 
as nurses’ primary function is to render nursing care depending on other health workers 
and support services for on-site provision of service delivery resources.   
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2.9 PROVINCES OF THE REPUBLIC OF SOUTH AFRICA’S SITUATION ON 
MEDICINE AVAILABILITY  
 
When assessing the number of provinces publishing availability details in their annual 
performance plans for the 2010/2011 financial year it becomes clear that not all nine 
provinces have readily available information on medicine availability. Information 
regarding the availability of medicine usually emerges through the media when there 
are challenges with stock outs and as reaction to criticism by civil society lobby groups 
including Treatment Action Campaign and Section 27.  
 
2.9.1 Gauteng  
 
In the 2010/2011 Annual Report the province reported 98% medicine availability across 
all its hospitals, community health centres and primary health care clinics. 
 
The provincial report mentioned that in instances where medications were reported to 
be out of stock, substitutes were provided. Required medicine was also purchased from 
alternative suppliers in order to ensure continuity of care. District pharmacy monitoring 
and evaluation teams were also established to strengthen Pharmaceutical Services at 
PHC level through improved processes, supervision and training (Gauteng Department 
of Health 2011:50). The 2011 Facilities Baseline Audit on six priorities compliance 
reported that medicine availability was at a 68% average against a target of 100% in the 
province (HST 2013:16). The reports of non-availability of medicines continued to 
surface in 2012. Once again the province experienced medicine shortages and stock 
outs across the different districts. According to Bloom (2012:5) it was reported that 
these shortages were due to non-payment of suppliers which resulted in the withholding 
of deliveries to the health facilities. This resulted in patients going without treatment for 
diabetes, hypertension and other chronic diseases. 
 
2.9.2 Limpopo 
 
According to a study conducted on medicine shortages in Limpopo’s Mopani district the 
non-availability of tracer (essential) medicines was found to be at an average of 24,8%. 
Medicine non-availability was found to be due to the following additional factors: poor 
quantification practices by the primary health care staff, as personnel would order 
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medicine without regarding minimum and maximum stock levels required for the facility; 
stock out from the Medical Depot, as facilities were out of  Paracetamol for 4 months; as 
well as poor supervision resulting in shortages being identified at an advanced stage 
and irrational prescribing by the health professionals  as evidenced by  overuse of  
antibiotics ( Matse 2006:52). 
 
The increase in the number of patients visiting primary health care due to health policy 
changes post democratic government - which classified primary health services as free 
– and medicine shopping behaviour by the patients visiting more than one facility 
without allowing the original prescription to take effect was cited as also playing a role in 
the Limpopo province non-availability of medicines (Baloyi 2009:28). The average 
medicine availability in this province was at an average of 43% in the year 2011 during 
the ministerial commissioned baseline audit (HST 2013:17). 
 
2.9.3 Western Cape  
 
The National Health Facilities Baseline Audit conducted in the province in 2011 reported 
an average medicine availability of 60% (HST 2013:19). 
 
There were also reports indicating that provincial public patients with chronic conditions, 
including diabetes, had to go without their lifesaving medicines in 2010 and again in 
2012. The blame for the shortage was placed on the failure of suppliers and distribution 
contractors. These glitches resulted in long waiting times and patients being turned 
away without medicine. These shortages occurred despite the outsourced management 
of distribution of medicines with a private company with a clear mandate to ensure 
continuous uninterrupted supply of medicine (Fokazi 2012:7).   
 
2.9.4 KwaZulu-Natal  
 
The province reported an estimated 15% and 10% essential medicine non-availability 
for the Medical Depot and facilities respectively in its annual reports for 2010 and 2011. 
The factors mentioned were poor monitoring in Medical Depot and facilities and limited 
storage space for buffer stock (KwaZulu-Natal Department of Health 2011:157).The 
National Health Facilities Audit reported 56% average availability of medicines in the 
year 2011 (HST 2013:17). 
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2.9.5 Northern Cape  
 
In 2008 it was found in this province that, out of the essential list of 39 items common to 
all health facilities, the number of items out of stock ranged from 2 to 25, which 
translated into between 5% and 64% on the day of the assessment by the investigation 
team commissioned by the provincial government. The non-availability of medicine was 
reported to be influenced by the inadequate and inappropriate pharmaceutical staff 
numbers, as the dispensing and ordering was done mainly by nurses instead of 
pharmacy professionals, an inadequate distribution system, and, to a lesser extent, poor 
supplier performance (Strengthening Pharmaceutical Services 2008:27). By 2011 the 
poor medicine availability situation had not improved as the province was found to be at 
an average of 42%, which was the lowest of the nine provinces in the country. The audit 
outcome recommended that this province needs to be assisted in order to improve on 
their performance (HST 2013:18).  
 
2.9.6 Mpumalanga, Eastern Cape and Northwest Provinces  
 
The above three provinces did not publish their annual report information on medicine 
availability.   
 
2.10 FREE STATE PROVINCIAL CONTEXT OF MEDICINE AVAILABILITY 
 
The Free State Province has also not been able to continuously ensure the availability 
of medicine required to treat prevailing health conditions within the province. In the 
National Primary Health Care Survey conducted during 2003 only 10% of Free State 
Primary Health Care Facilities were found to have a full complement of essential 
medicines (Health Systems Trust 2004:35). Furthermore, the Free State District Health 
Services’ medicine availability reached an average of 45% during April 2009, resulting 
in patients dying whilst on the waiting list for antiretroviral medication (Free State 
Department of Health (FSDOH) 2009:1).  
 
As reported in the 2010 patient satisfaction survey, 12% of clients who visited Free 
State District Health Services during March 2010 reported non-availability of medication 
during their visit (Survey Workshop 2010:15). 
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In 2012 the respondents in the patient satisfaction survey indicated that amongst the 
main medicines not always available were chronic medicine for diabetes management 
and hypertension, as well as acute medicines for influenza and minor ailments ranked 
the highest in primary health care settings. In hospitals acute medicines were highest on 
the list of medicines reported to be frequently unavailable (Survey Workshop 2012:15). 
The inability to provide the required quantity and quality of health care service, including 
consistent availability of essential medication and consumables, were identified as 
amongst the top 10 strategic risks for the Free State Department of Health. 
 
The causes of the inability to maintain acceptable medicine stock levels was reported as 
being budgetary, supply and logistical failures (FSDOH 2010:41). In an attempt to 
improve medicine availability the Provincial Strategic Plan of 2010-2014 required the 
availability of medicine to be maintained at an average of at least 95% across all levels 
of care (FSDOH 2010:49). However, the Free State Department of Health has failed to 
maintain the required average level of 95 % medicinal availability over the years (Free 
State Provincial Government 2012:17). 
 
The insufficient procurement and distribution of medicine was identified as being 
amongst the key service delivery challenges facing the Department of Health in the 
Free State to achieve the set target (FSDOH 2010:10). 
 
Another assessment into the availability of medicine conducted by HST in 2011 as part 
of the National Health Facilities Baseline Audit also demonstrated that the majority of 
Free State Primary Health Facilities across the five districts were found non-compliant 
with the medicine availability standards at an average of 54% (HST 2013:16). 
 
Furthermore, according to the annual report for medicine availability in the five districts 
during 2011 calendar year, there was still a below acceptable average availability of 
95%. The 2011/2012 Free State Provincial Government Annual Report reflects an 
average of 92% medicine availability for the province (Free State Provincial 
Government 2012:17).  
 
Early in 2012 the province was once again reported in the media as not having sufficient 
stock of antiretroviral and TB medicines, resulting in patients once again not receiving 
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the required medicines (FSDOH 2012a:1). The medicine stock out continued to exist 
towards the end of the year as another study reported 89.4% availability of ARVs and 
TB medicines in one district. This was said to be mainly due to poor stock management 
practices (Pure Health Consulting 2012:34).   
 
The medicine stock out was accepted by government to be in the supply of the 
antiretroviral (Stavudine and Tenofovir), TB medication (INH 100mg and 300mg), as 
well as Actraphane (insulin prescribed for Diabetes Mellitus). The non-availability was 
said to be due to the inability of the pharmaceutical manufacturers of these essential 
medications to keep up with the demand from the various provinces (FSDOH 2012 a:1). 
 
The factors contributing to the below norm availability included poor supplier 
performance, unreliable distribution mechanisms from the Medical Depot, and poor 
ordering patterns by health institutions. The situation that was brought on by the non-
availability of medicines, including antiretroviral treatment, and exposed the Department 
of Health to various negative perceptions within the media (Health 24:2010). 
Furthermore, patients with chronic conditions, including hypertension and diabetes, 
found themselves without their medication or injections for controlling these conditions. 
 
As a result the quality of services offered was compromised and in turn this situation led 
to poor health outcomes causing patients to default on their treatment. These problems 
were in contrast with the South African Government’s Health Ten Point Plan, which 
emphasises the need to ensure sufficient availability of medication at an acceptable 
norm of 95% for essential medicines (FSDOH 2010:49). 
 
According to an MSH investigation conducted in 2009 at the request of the department, 
the problem seemed to arise from various internal factors, rather than external factors, 
and needed to be investigated to prevent re-occurrence in the future. Possible factors 
which inhibit the availability of medicine in the Free State District Health services 
included the following: 
 
Firstly, it may be that the Free State Department of Health has failed to fully understand 
and appreciate the fact that medicine is costly. Therefore, medicine has to be managed 
differently from any other hospital supplies. 
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Secondly, a dysfunctional and unrealistic organisational structure led to inadequate 
financing and an unreliable, incoherent information management system for medicine 
provision. This resulted in patient care suffering the consequences, as evidenced by the 
fact that the policy making and oversight unit for medicinal policies is located in a 
different directorate than the Medical Depot which is responsible for procurement and 
distribution of medicines to the five districts. This situation has an impact on the 
availability of medicines as the decisions are taken in another unit other than the 
Medical Depot and medicine stores.  The investigation by MSH further suggested that 
the positioning of the Medical Depot within the Finance cluster and its regard as a 
trading entity primarily, focusing on financial viability rather than on citizen’s accessibility 
to medicine of adequate quality, is a challenge. 
 
Lastly, the quality and quantity of qualified dispensing professional nurses and 
pharmacists also contributes to the reduced availability of medication, as inconsistent 
ordering was observed in areas with less skilled personnel and high staff shortages 
(MSH 2010:3). 
 
2.11 CONCLUSION  
 
The failure to ensure consistent availability of medicines and compliance with the set 
national core standards has the potential to affect the implementation of the National 
Health Insurance plan. This is because the recruitment of private General Practitioners 
to support primary health nurses in the provision of health services will also require 
additional available medicine stock, as doctors will prescribe medicine of higher 
restrictions in the clinic, which was not the case before due to non-availability of doctors 
within primary health services (Paradath & English 2013 :16). 
 
It is, therefore, of utmost importance and necessity to explore further which factors 
contribute to the availability of medicine in the five districts of the Free State Province’s 
health services. 
 
 
  
41 
CHAPTER 3 
 
RESEARCH DESIGN AND METHOD 
 
 
3.1 INTRODUCTION  
 
In this chapter the study’s research design, methodology, population, sampling, data 
collection, and analysis as well as the ethical considerations will be explained.  
 
3.2 RESEARCH PURPOSE, OBJECTIVES AND QUESTIONS  
 
3.2.1 Research purpose 
 
The purpose of the study was to investigate the factors affecting the availability of 
medicine in the various Free State districts’ health services. 
 
3.2.2 Research objectives 
 
 Explore and describe the factors affecting the availability of medicine in the 
various Free State districts’ health services. 
 Make recommendations on corrective measures to be implemented to improve 
the availability of medicine in the various districts’ health services in the Free 
State. 
 
3.2.3 Research questions  
 
 What are the factors that contribute towards insufficient availability of medicine in 
the District Health Services in the Free State?  
 How can the Free State Department of Health ensure sufficient medicine 
availability in the District Health Services of the Free State? 
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3.3 RESEARCH DESIGN  
 
Research design is concerned with what the researcher intends to study and the data 
collection and analysis methods to be utilised in the process (Barbie 2010:91).  
 
According to Welman et al, (2005:52) the research design is the plan according to which 
we obtain research participants and collect information from them to reach conclusions 
about a research problem. This research was conducted through experiences of the 
managers responsible for provision of medicine in the five districts. In this study the 
design used had to provide for in depth narrative and content rich data. It is for this 
reason that the qualitative exploratory, descriptive and contextual research design was 
chosen to allow for the respondents to share first-hand experience of the subject under 
investigation in order to produce quality research information.  
 
3.3.1 Qualitative research design  
 
Qualitative research designs aim for understanding the significance which respondents 
attach to their environment as well as enabling the researcher to change the data 
progressively so that deeper understanding of what is being investigated can be 
achieved (Welman et al 2005:8). Qualitative research design is a naturalistic enquiry 
which is usually less obstructive than quantitative investigations and does not 
manipulate the research setting. It aims to understand the individual’s view without 
making any value judgement during data collection. The focus of qualitative studies is 
on the meaning that the participants attach to their social world (Bowling 2009:380). 
Marshall and Rossman (2011:2) also confirm that qualitative research is typically 
enacted in a naturalistic setting focusing on context, is emergent and evolving as well as 
fundamentally interpretative. According to Barbie (2010:92), the purpose of conducting 
qualitative research can be exploration, description and or explanation of a 
phenomenon.  
 
Qualitative research design was found to be suitable for this research as it explored and 
described in an uncontrolled setting the experiences of the managers responsible for 
provision of medicines in the Free State Province with the intention of obtaining rich 
explanations and understanding of the factors affecting medicine availability. 
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3.3.2 Exploratory research 
 
Exploratory research is used to understand the phenomenon under study by employing 
an open, flexible and inductive approach in an attempt to look for new insights into the 
phenomenon under study (Terreblanche, Durrheim & Painter, 2006:44). Exploratory 
research is further described as research which is conducted to obtain more details on a 
poorly understood phenomenon and develop preliminary ideas about it and move 
towards refined research questions (Neuman 2011:38). 
 
Exploratory research is useful in conducting studies with the intention to yield new 
insights into the research topic (Barbie 2010:93). In this study the researcher intended 
to explore and describe factors affecting medicine availability through the experiences 
of managers directly involved with the phenomenon. 
 
3.3.3 Descriptive research 
 
According to Barbie (2010:93), the major purpose of social sciences studies is to 
describe situations and events (in our case medicine availability). Descriptive studies 
enable researchers to present a picture of the specific details of a situation, setting or 
relationship by focusing on explaining why something happened (Neuman 2011:39). 
This study intended to describe factors affecting the availability of medicines within the 
district health services as such exploratory and descriptive research approach was 
found to be relevant for the study. A descriptive research design is suitable for the 
purpose of identifying problems with current practice or justification thereof (Burns & 
Grove 2005:232). 
 
3.3.4 Contextual design  
 
Qualitative researchers conduct research to make sense of feelings, experiences, social 
situations and phenomena as they occur in the real world (Terreblanche et al 
2006:287). Human behaviour and experiences cannot be understood without 
appreciating the environment in which it occurs. Thus it is important to understand the 
context under which the research is conducted (Welman et al 2005:91). The conduct of 
qualitative research is better executed in an environment that is natural and 
uncontrolled (Burns & Grove 2005:25). 
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This study was conducted in the health services setting focusing on the provision of 
medicines within the district health services in a relatively rural province comprising of 5 
districts.  Each district possesses facilities ranging from primary health clinics to district 
hospitals, which all form a referral chain for the rendering of health services inclusive of 
medicine provision to service users. The Free State’s district health services provide 
services to at least three million patients annually.  
 
3.4 RESEARCH DATA COLLECTION METHOD 
 
Qualitative researchers are interested in making sense of feelings and experiences as 
they occur in the real world with minimal disturbance of the context in an attempt to 
become a natural part of the context by engaging with researchers in an open and 
empathic manner (Terreblanche et al 2006:287). Researchers conducting qualitative 
research utilise methods that are unique to qualitative studies which focus on words 
rather than numbers (Burn & Grove 2005:535). Qualitative research involves several 
methods of data collection such as focus groups, field observation, in-depth interviews 
and case studies to obtain rich data (Wimmer & Dominick 2006:48). The method 
selected for this study was focus group discussions through in depth interviews with the 
participants to obtain a detailed explanation of the experiences in relation to medicine 
availability. 
 
3.4.1 Focus Group Discussions 
 
Marshall and Rossman (2011:93) recommend that, in order to capture the individuals’ 
lived experiences, an in depth interview should be used to capture the deep meaning of 
experience in the participant’s own words. Furthermore, Wimmer and Dominick 
(2006:116) indicate that qualitative research uses a flexible questioning approach. 
Although a basic set of questions is designed to start the project, the researcher can 
change questions or ask follow-up questions at any time. In the process of conducting 
this study, the researcher utilised focus group discussion.  
 
Focus groups are the qualitative research design technique in which people are 
interviewed in a group setting (Neuman 2011:458) allowing the researcher to obtain in-
depth descriptive data. Burns and Grove (2005:542) explain that focus groups are 
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designed to obtain the participants’ perceptions in a focused area and in a setting that is 
permissive and non-threatening.  
 
The focus groups were conducted using the semi structured interview approach, and 
focus group discussions were utilised in order to explore the experiences of the 
participants. The process was expounded by providing the respondents of both focus 
groups with a short questionnaire to capture demographic details, as well as to record 
responses to certain predetermined questions. Wimmer and Dominick (2006:130) refer 
to this as an extended focus group. Two focus groups were held separately: one group 
consisting of the pharmaceutical service managers and the second group with district 
health managers. Neuman (2011:460) recommends that focus groups should be 
segmented by status as people often respond very differently when people of higher or 
lower status are present.  
 
The focus groups discussions were conducted on different days in a research facility 
equipped with audio recording facilities. The setting promoted proper conduct of the 
study and allowed for an in-depth understanding of the problems faced by the 
participants regarding medicine availability. There are various advantages to focus 
group discussions, namely that the researcher can view behaviour in a natural setting, 
excluding the artificiality that sometimes surround experimental research, and the 
fostering of social support networks as the participants engage and reflect on the 
research topic under discussion (Marshall & Rossman 2011:150). Furthermore, this 
technique can increase the depth of understanding that the researcher may gain from 
the experience. 
 
According to Wimmer and Dominick (2006:130) and Barbie (2010:323), focus groups 
have additional advantages, including the depth and wealth  of information that can be 
gained at minimal cost to the group and the flexibility in question design and follow-up. 
Finally, this method allows flexibility in questioning and clarity regarding information that 
is collected from the respondents (Wimmer & Dominick 2006:49). Focus groups make 
use of group dynamics to stimulate, gain insights and generate ideas in order to pursue 
a topic in greater detail (Bowling 2009:424). Focus groups are recommended for 
conducting qualitative studies, because they facilitate the participation of more than one 
person, allowing the process to generate a wider variety of information than if there 
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were fewer participants as immediate follow-up and clarification are possible (Marshall 
& Rossman 2011:145). 
 
The possible disadvantage of the focus group discussions is that some participants are 
intimidated by speaking in a group (Welman et al 2005:204). This was overcome by the 
fact that the participants were familiar to each other as they currently work together in 
the department. 
 
Different views exist on the number of participants in focus group discussions. One view 
is that a focus group should comprise between 6 and 12 participants (Burns & Grove 
2005:543). The other view is that the focus group could comprise of 5-15 participants 
brought together in a private, comfortable environment to engage in a guided discussion 
of some topic (Barbie 2010:322). Wimmer and Dominick (2006:128) indicate that the 
focus group is a research strategy for understanding audience attitudes and behaviour 
where no more than 12 people are interviewed simultaneously with a moderator leading 
the respondents in a relatively unstructured discussion about the focal topic. For this 
study two groups were purposely selected for their role in and experience of medicine 
provision. The participants were ranging between 6 and 7 participants per group in 
order to comply with the standard set for the conduct of focus group discussion. The 
total number of participants for this study was 13 and the interviews were conducted in 
Bloemfontein during August 2012. 
 
3.4.2 Study population  
 
According to Terreblanche et al (2006:133), population is the larger pool from which the 
sampling elements are drawn and to which we want to generalise the findings. Barbie 
(2010:199) defines the study population as the aggregation of elements from which the 
sample is actually selected. Welman et al (2005:52) defines the population as that 
group which encompasses the total collection of all units of analysis about which the 
researcher wishes to make specific conclusions .The population for this study was the 
pharmaceutical managers and the district health services managers within the Free 
State province comprising of: 
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 The seven pharmaceutical managers, including a responsible pharmacist, for the 
Medical Depot, Provincial Head of Pharmaceutical Services and five district 
pharmacists representing each of the five districts;   
 The District Managers group inclusive of all 5 District Managers and the Manager 
of the Medical Depot who were all professional nurses.   
 
The core function of the study population is to ensure provision of quality health 
services and medicines to the Free State Communities within a district level setting.  
 
3.4.3 Sampling framing  
 
A sampling frame is a list of units composing a population from which a sample is 
selected (Barbie2010:208). The sampling frame enables the researcher to choose the 
cases suitable for the study (Terreblanche et al 2006:133). The cases in the qualitative 
research are called participants or informants for the purposes of the study. Welman et 
al (2005:204) recommend that, for qualitative studies, participants should be obtained 
through purposive sampling with the intention to identify and select key informants who, 
on account of their position or experience, have more information than regular group 
members. The participants for this study were identified through a review of the 
organogram and the staff establishment for district health services in order to identify 
officials responsible for the provision of medicine. They would be able to provide a rich 
explanation and description of the factors affecting medicine availability. 
 
3.4.4 Purposive sample selection  
 
Purposive sampling was used to identify and select the individuals that have more 
information than the regular group members (Welman et al 2005:204). Burn and Grove 
(2005:353) explain that purposive sampling involves conscious selection of certain 
subjects to include in the study by the researcher. The selected subjects should present 
information rich cases from which the researcher can learn a lot about the central focus 
of the study. Barbie (2010:193) defines purposive sampling as the selection of the 
sample on the basis of knowledge of the population, its elements, and the purpose of 
the study.  
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According to Neuman (2011:268), purposive sampling is appropriate for selecting 
unique cases that are especially informative in order to gain deeper understanding of 
the phenomenon under study. For this study the five district and two provincial 
pharmaceutical managers as well as five district managers and the Manager for the 
Medical Depot were selected as a sample on the basis of their experiences and their 
prominent responsibility in the provision of medicine. The seven managers of 
Pharmaceutical Services were all responsible for the provision of medicine to the health 
care facilities, as well as the custodians and originators of the reports on medicine 
availability. They were labelled Focus Group #1. The second group comprised of the 
five district health care managers and Manager Medical Depot as the key informants 
responsible for provision of health services within the first level of care. They were 
labelled Focus Group #2. 
 
3.4.5 The role of the researcher during focus groups  
 
Qualitative researchers are not independent or separate from the research process. 
They interact with the group being studied to promote direct understanding of the 
phenomenon under study (Welman et al 2005:191). In qualitative studies the researcher 
is the instrument of observation and recording of human behaviour in the context of 
interaction (Terreblanche et al 2006:51). Furthermore, the researcher observes the 
social behaviour and may participate in social interaction with those being studied 
(Burns & Grove 2005:536). The researcher was present during the interviews, taking 
notes and observing the interaction and the discussions through a one way mirror to 
ensure that the research questions were addressed. The researcher also submitted 
additional clarity seeking questions through the facilitator to the group in order to allow 
the participants to freely express their views without being intimidated and disturbed by 
the researcher’s presence and note taking.  
 
3.4.6 The role of the facilitator  
 
Focus groups require skilled interviewers as moderators/facilitators in order to control 
the group dynamics and avoid domination by the other interviewees in the discussion 
(Barbie 2010:323). To avoid biased results and ensure balanced proceeding of the 
discussions a facilitator for the focus groups was appointed. The facilitator is an 
experienced researcher who has conducted previous focus groups in a health related 
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fields using qualitative research approaches and holds a PhD. The facilitator’s role was 
to clarify, paraphrase and reflect back what has been said by the participants. The 
facilitator should also remain neutral and non-judgemental in the process (Burns & 
Grove 2005:544). This was monitored throughout the conduct of the focus group 
discussions by the researcher. In the instances where the facilitator deviated from the 
discussion brief, a runner was given written communication to guide the facilitator to 
carry out his facilitation role in a neutral and non-judgemental manner. 
 
3.5 DATA COLLECTION AND ANALYSIS  
 
Data collection is the process of gathering information relevant to the study using one of 
the following primary methods: participating in the setting, observing directly, 
interviewing in depth, and analysing documents (Marshall & Rossman 2011:137).  
 
The data collection process in qualitative studies aim for rich, narrative accounts of the 
phenomenon under study. As such, the chosen collection method should capture the 
experiences and views of the participant in expressed words format (Streubert & 
Carpenter 2011:38). Focus group interviews were found suitable for this study. Creswell 
(2013:177) also support the view that data collection could be done in many forms, 
including interviews, observation, documents and audio-visual equipment for qualitative 
studies. 
 
3.5.1 Data collection through interviews  
 
Qualitative interview is an interaction or a conversation between the interviewer and the 
respondents in which the interviewer has a general plan of inquiry including the topics to 
be covered (Barbie 2010:318).  
 
For this study the data collection was executed by using the interview as a main 
strategy coupled with a structured questionnaire to answer specific predetermined 
research questions with a separate section for completion of demographic data 
including experience and main responsibilities. Having a questionnaire did not mean 
that this set of questions should be asked in particular words or in a certain order, but 
followed the flow of the interview discussions. 
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3.5.2 Interview guide 
 
Prior to the focus group an interview guide was developed in order to assist the 
facilitator of the focus group in collecting the relevant information from the respondent. 
The interview guide should not exceed five pages and should contain no more than 
seven open ended questions which are developed from the research question (Creswell 
2012:164). A set of predetermined questions were developed. However, the existence 
of an interview guide did not mean that the facilitator could not ask questions not 
contained in the guide (Wimmer & Dominick 2006:133). The facilitator was allowed to 
ask follow-up questions or probe respondents’ comments during the session to gain 
further insight. 
 
Respondents were asked the central question: “Describe your experiences regarding 
medicine availability, and also describe factors affecting availability of medicine within 
the facilities of the Free State district health services”.  
 
3.5.3 Interview setting 
 
The researcher should provide an environment that is comfortable for the interviewees 
with the recording equipment placed unobtrusively (Burns & Grove 2005:540). Each of 
the two focus group interviews took place at a focus group facility in Bloemfontein using 
the developed interview guide. The interview process was digitally recorded for 
reference purposes as well as for the transcribing of the discussions, which is essential 
in the analysis of the data collected. Rapport and trust is essential for the conduct of an 
effective interview session (Welman et al 2005:199).The researcher and the participants 
were employed by the same department and have a working relationship. As such there 
was trust and rapport to promote free and open interaction during the interview 
sessions. 
 
3.5.4 Data analysis  
 
Qualitative data analysis is a search for general statements about the relationship and 
underlying themes in a study (Marshall& Rossman 2011:207). Data analysis in 
qualitative research consists of preparing and organising the data for analysis then 
reducing the data into themes through a process of coding and condensing the codes, 
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and finally representing the data in figures, tables or a discussion (Cresswell 2013:180). 
According to Corbin and Strauss (2008:66), data analysis involves taking raw data and 
raising it to the conceptual level. Data analysis for qualitative studies progresses 
through classification of ideas, themes, topics, activities, and types of people as well as 
other categories relevant to the study (Schensul & Le Compte 2013:98). The goal of 
data analysis is to illuminate the experiences of those who have lived them by sharing 
the richness of lived experiences and cultures (Streubert & Carpenter 2011:47). 
 
De Vos, Strydom, Fouche and Delport (2005:333) define data analysis as the process 
of bringing order, structure, and meaning to the mass of collected data aimed at 
searching for general statements about relationships among the categories of data. 
There are nine overlapping steps for qualitative research data analysis, namely  
managing or organising the data, reading and writing memos, generating categories, 
themes and patterns, coding the data, testing the emergent understandings, searching 
for alternative  explanations,  and  representing and visualising the data in report format 
(De Vos et al 2005:334). Data analysis involves organising the data, preliminarily 
reading through of the database, coding and organising themes, representing the data 
in a meaningful format and forming of an interpretation thereof. 
 
These steps are interconnected and form a spiral of activities all related to the analysis 
and representation of the data (Creswell 2013:179). The aim of data analysis is the 
discovery of patterns among the data; patterns that point to theoretical understanding of 
social life (Barbie 2010:400). 
 
3.5.5 Data analysis processing  
 
Data for this research originated from the transcripts made of digital recordings and 
notes that were collected during the focus group interviews.The data were then 
organised and analysed by means of an inductive model in order to ensure that the data 
that is relevant and related to a particular theme was grouped into appropriate and 
meaningful categories. Coding was used to classify elements in text data into categories 
that are related to the study topic and useful for analysis (Schensul & Le Compte 
2013:98).  
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Computers and technology can be utilised for qualitative data analysis because of their 
inherent advantages, including sorting and organising the data to make sense of the 
collected information (Burns & Grove 2005:546). The data analysis process for this 
study was enhanced by the use of the Xsight a software package that was developed 
for the analysis of qualitative data. XSight software assists researchers or other 
professionals working with non-numerical or unstructured data to compile, compare and 
make sense of collected information. 
 
XSight provides a range of analysis frameworks for importing, classifying and arranging 
data, tools for testing theories and relationships between items, plus the ability to 
visually map and report thoughts as well as the findings. This software package is 
designed for rapid analysis with the potential to handle small or large volumes of data. 
Using the search tools supports the review and reflection process and enables users to 
look for patterns, make comparisons and interrogate the data to obtain the explanations 
of the phenomenon under study (QSRI 2008). 
 
3.6 TRUSTWORTHINESS 
 
Trustworthiness is the extent to which the study can be regarded as reliable and 
produced credible findings.Lincoln and Guba (1985) suggest that credibility, 
transferability, authenticity, and confirmability should be demonstrated in a qualitative 
study (Creswell 2013:246). 
 
The trustworthiness and validity of qualitative studies is concerned with the truthfulness 
of the data collected with special emphasis on conveying the insider view and providing 
a detailed account of how the people we are studying understand the phenomenon 
(Neuman 2011:214).Trustworthiness comprises the extent to which the study has the 
potential to produce credible findings and interpretation of the phenomenon under 
study. The test of trustworthiness can thus be described as whether or not the study 
investigates the proposed research questions. All the necessary precautions were taken 
to ensure trustworthiness through identification and selection of appropriate informants 
as well as conduct of the research focus group discussion at the facility with an 
experienced researcher as the facilitator. Furthermore, the design and refinement of the 
interview guide ensured that the research questions are addressed. 
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The elements of credibility, confirmability, and transferability were promoted in the 
conduct of the study as discussed below.  
 
3.6.1 Credibility  
 
Credibility of a qualitative study is established while the research is being undertaken 
(Terreblanche et al 2006:90). According to Lincoln and Guba (1985), credibility includes 
activities that increase the probability that credible findings will be produced. Credibility 
can also be enhanced by returning to the participants to assess whether they recognise 
the findings (Streubert & Carpenter 2011:48). The study was undertaken over time with 
approval from the university’s ethics committee and allowing for prolonged engagement 
with the participants in a familiar environment under the guidance of the supervisors 
who are seasoned, qualified, and experienced researchers as mentors throughout the 
lifespan of research project. Cross checking of data with the participants ensured that 
what is reported are the views of the participants. Furthermore, the researcher 
underwent preparation in advanced research methodology as part of the studies for the 
Honours Degree in Health Studies.  
 
3.6.2 Confirmability 
 
Confirmability is the extent to which the research findings can be verified or confirmed 
by another person (Marshall & Rossman 2011:253). Confirmability was achieved by 
keeping an audit trail, namely the written and audio records of information collected over 
time, to enable other researchers to verify the findings of the conducted research. A 
reference list could also be beneficial in facilitating the identification of reference 
material used in doing the research. For this study the audio and written notes and 
reference materials are available for verification purposes. 
 
3.6.3 Transferability  
 
Transferability is the extent to which the research finding can be applicable to other 
similar situations. Streubert and Carpenter (2011:49) define transferability as the 
probability that the study findings have meaning to others in similar situations and 
submit that the transferability possibility rests with potential users of the findings and not 
the researchers. Terreblanche et al (2006:92) explain that transferability is achieved by 
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producing detailed and rich descriptions of context, and that this provides the reader 
with a detailed account of the structured meaning which develops in a specific context. 
According to Wimmer and Dominick (2006:27), transferability is the level to which the 
results can be generalised to the population.  
 
For this study the quality, credibility, confirmability, and dependability of work produced 
will assist in determining transferability. Transferability is determined by the readers of 
the research report and not by the researcher, as in this study the purpose is to explore 
and describe the factors affecting medicine availability in the Free State Province district 
health services context. 
 
3.7 ETHICAL CONSIDERATIONS 
 
Wimmer and Dominick (2006:69) provide general ethical principles which the 
researcher should consider.  The first is autonomy, which has its roots in the categorical 
imperative and demands the researchers respect the rights, values and decisions of 
other people. The second is nonmaleficence, which is the avoidance of intentional harm 
to respondents, and beneficence, which stipulates that a positive obligation to remove 
existing harm can be identified. Lastly, the principle of justice holds that people who are 
equal in relevant respects should be treated equally. The research conduct process 
should not cause harm to the participants and organisations, thereby supporting the 
principle of beneficence (Streubert & Carpenter 2011:60). According to Wimmer and 
Dominick (2006:67), there are various reasons for ethical behaviour. These include that 
unethical behaviour may have an adverse effect on the participants, and that unethical 
research practices reflect poorly on the profession. In a clinical or health environment 
the researcher will come into contact with health professionals and their patients, 
possibly invading their work space, which is normally managed by authorities. 
 
The researcher ensured compliance with principles of ethical research throughout the 
study period by implementing the measures required for conformance with the 
principles of autonomy, beneficence, justice and informed consent as explained below. 
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3.7.1 Ethical clearance 
 
Ethical clearance for this study was obtained from the University of South Africa and 
approval to conduct the study was obtained from the Head of Department of the Free 
State Department of Health (see Annexure A and B).  
 
3.7.2 Human rights and principles of justice  
 
Human rights can include the right to self-determination, privacy, anonymity, and 
protection from harm (Burns & Grove 2005:181). The principle of justice is concerned 
with fair treatment, right to privacy, and anonymity (Streubert & Carpenter 2011:65). 
 
3.7.3 Right to self-determination (autonomy)  
 
The prospective participants should have the opportunity to choose whether or not to 
participate in the study (Burns & Grove 2005:1930). The potential respondents were not 
forced or coerced into being part of the research by being promised rewards, but did so 
with the full understanding that their contribution might build knowledge for effective 
health services through improving medicine availability. The participants were informed 
of their right to withdraw at any time or reserve their comments and inputs without being 
penalised.  
 
3.7.4 Informed consent  
 
According to Polit and Beck (2004:151), informed consent means that participants have 
adequate information regarding the research and are capable of comprehending the 
information. They also have the power of free choice which enables them to consent 
voluntarily to participate in the research or decline participation. 
 
Informed consent consists of four elements namely: disclosure of essential information, 
comphrehensionability, competency and voluntarism (Burns & Grove 2005:193). The 
reasons, benefits, impact, and content of the research, as well as the criteria for being 
chosen were provided to the potential participants prior to commencing the study.  This 
enabled the participants to decide whether or not to take part in the research. 
  
56 
All participants in this study were above the consenting age of 18 years and have basic 
understanding of the research. They also received written requests to voluntarily 
participate in the research and signed a voluntary consent form for participation in the 
study on acceptance (see Annexure C). 
 
3.7.5 Privacy and confidentiality 
 
Researchers have a responsibility to protect the anonymity of subjects and to maintain 
the confidentiality of data collected during the study (Burns & Grove 2005:188). The 
participants’ names and personal identifying information were not used in the records. 
Instead, symbols were used as codes and personal details will only be accessed by the 
researcher and the supervisors. Should personal information be necessary for reporting 
purposes the permission of the affected participant will be sought. 
 
3.7.6 Respect 
 
The participants were not judged for their responses or experiences. All inputs were 
regarded as valuable; contributing to realising the purpose of the research. 
 
3.8 RIGHTS OF THE INSTITUTION 
 
The institutional routine and integrity should be respected during the research process 
(Creswell 2013:58). Integrity was maintained during the conduct of the study through 
proper arrangements for conducting the research focus groups interviews, such as that 
there was no interference with the participants’ routine and the supervisor’s permission 
was sought. 
 
3.8.1 Permission to conduct research  
 
An application to the Head of the Department and Research Committee was submitted 
indicating the duration and nature of research to be conducted and was approved in 
writing prior to the commencement of the research. 
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3.8.2 Privacy  
 
In this study there was no direct mention of the facilities or names of any member of the 
health care facilities management in order to maintain the integrity, privacy, and image 
of the district facilities involved. 
 
3.9 SCIENTIFIC HONESTY OF THE RESEARCHER  
 
The goal of the research is to generate sound and scientific knowledge, which is only 
possible through the honest conduct, reporting and publication of studies (Burns & 
Grove 2005:203). While conducting the study the researcher should not falsify 
authorship, evidence, data, findings, or conclusions, and should neither plagiarise nor 
disclose information that will harm the participants (Creswell 2013:59). 
 
The researcher submits that the following was complied with during the research 
process: 
 
 Accurate recording  and reporting of study findings;  
 Reported only the truth on the experiences of district pharmaceutical  managers 
and  without distorting the acquired information to meet the needs and beliefs of 
the researcher; 
 Acknowledged all sources ideas and processes and words used or obtained from 
other authors’ work;  
 Utilised the tested means in obtaining data and conducting the research;  
 Did not coerce or manipulate participants into taking part in the research. 
 
3.10 CONCLUSION  
 
This chapter presented the methodology followed in conducting the study. In the next 
chapter the data collected will be presented, so doing expressing the views of the 
managers on the topic under study. 
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CHAPTER 4 
 
DATA ANALYSIS AND PRESENTATION OF FINDINGS 
 
 
4.1 INTRODUCTION  
 
The previous chapters have provided background to the research by providing the 
literature review and the methodology followed in conducting the study. In this chapter, 
data collected during the focus groups and analysed will be presented. 
 
4.2 DATA MANAGEMENT AND ANALYSIS  
 
De Vos et al (2005:333) define data analysis as the process of bringing order, structure, 
and meaning to the mass of collected data. It is aimed at searching for general 
statements about relationships among the categories of data. Data analysis involves 
organising the data, conducting a preliminary reading through of the database, coding 
and organising themes, representing the data, and forming of an interpretation thereof.  
 
These steps are interconnected and form a spiral of activities all related to the analysis 
and representation of the data (Creswell 2013:179). The process followed in this 
research data analysis and presentation mirrors the steps for qualitative research data 
analysis, namely managing or organising the data, reading and writing memos, 
generating categories, themes and patterns, coding the data, testing the emergent 
understandings, searching for alternative explanations and  representing the collected 
data in a report format (De Vos et al 2005:334). The aim of data analysis is the 
discovery of patterns among the data to promote theoretical understanding of social life 
(Barbie 2010:400). 
 
Data analysis for this study utilised the spiral model as proposed by Creswell 
(2013:182-188) as follows. 
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Data organisation 
 
The data were audio recorded and then transcribed by a professional reader to produce 
a mind map and narrative written data using XSight software. 
 
Reading and memoing 
 
The transcribed data were read comprehensively to make sense of the collected facts 
before clustering the data in line with the research questions and the emergent themes.  
 
Description, classifying and Interpretation into codes and themes  
 
During this process the researcher compiled detailed descriptions of the experiences of 
the informants, highlighting the emerging themes and contrasting the collected data with 
the current literature and the researchers’ experience and views. The outcome was 
coding, which entails the clustering of data into small categories of information and 
labelling it. Barbie (2010:402) defines coding as the classification of individual pieces of 
data. Coding can be categorised into three classes, namely the initial classification and 
labelling of concepts, axial reanalysis of the results of open coding, and selective coding 
which seeks to identify the central code in the study. The data were then labelled into 
general themes, which are broad units of information that consist of several codes 
aggregated to form a common idea. 
 
Data interpretation  
 
Based on the developed codes and themes the researcher made sense of data through 
interpretation, reflecting and contrasting the findings with the current literature available. 
 
Data representation  
 
The data were then presented in a clustered theme approach reflecting the findings and 
identifying trends and practices affecting medicine availability. The collected information 
was then shared with the informants for validation as a true reflection of the discussions 
held. 
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4.3 RESEARCH RESULTS  
 
4.3.1 Sample characteristics  
 
It is important to note that the study was conducted after the period of reshuffling of the 
senior management in the department; hence, some managers had less than a year 
experience in management.  
 
The five Free State province districts, namely Thabo Mofutsanyana, Xhariep, 
Mangaung, Lejweleputswa and Fezile Dabi, were all represented in the focus groups. 
The pharmacist participants' primary role was defined by the participants themselves as 
that of ensuring sufficient, cost effective and efficient medicine provision within the 
district health services while the District Managers defined their role as that of being the 
ultimate accounting officers for the quality of health services including consistent 
availability of medicines within the district. 
 
 One District Manager stated that their role is to provide strategic leadership to 
ensure that the department strategic objectives are met, including provision of 
medicine. 
 One pharmacist participant put it: "So my duty is to ensure that there is coverage 
in terms of medicine availability throughout. I shouldn’t wait to hear from 
communities or ever complaining from somewhere – that is no. 1." 
 
Table 4.1 The profile of the participants  
 
GENDER  6 Male 7 Female    
AGE  10 (45-60 years) 1 (26-35 years) 2 (36-44 
years) 
  
MANAGEMENT 
EXPERIENCE IN 
YEARS   
5 (+5 years) 3 (2-5 years) 5 (less than 
a year) 
  
WORK 
EXPERIENCE 
YEARS 
7(+15  years) 3 (10-15 years) 2 ( 6-10 
years) 
1 (1-5 years )  
OCCUPATION 7 Pharmaceutical 
Services 
Managers 
6 Health 
Services 
Managers 
   
TOTAL     13 
  
4.3.2 Presentation of the research findings themes  
Table 4.2 Presentation of the research findings themes  
 
Category  Theme  Sub-theme  
4.3.2 Understanding of the concept 
medicine availability  
4.3.3.1 Medicine availability is understood 
differently in practice. 
 
4.3.3.1.1 All patients receive all the medications they 
need. 
4.3.3.1.2 From the Medical Depot's side, medicine is 
sufficiently available when they can satisfy 
100% of the demand.   
4.3.3.1.3 The availability should be in line with 
international standards.  
4.3.3 Status of availability of medicines 
in the various districts  
4.3.3.2 Medicine availability differs in each 
district. 
 
4.3.3.2.1 There is general acceptance that medicine 
availability in hospitals is within the required 
standards. 
4.3.3.2.2 The availability in Community Health 
Centres is below acceptable standards.  
4.3.3.2.3 The availability in primary health clinics is 
far below the required standards.  
4.3.4 Categories of medicine for 
consistent availability  
4.3.3.3 Certain medicines should always be 
available  
4.3.3.3.1 Tuberculosis  
4.3.3.3.2 Antiretroviral 
4.3.3.3.3 Vaccines  
4.3.3.3.4 Chronic Diseases   
 
 
4.3.5 Factors affecting the availability of 
medicines     
 
4.3.3.4 Certain factors negatively affect the 
availability of medicines  
4.3.3.4.1 Poor medicine stock management. 
4.3.3.4.2 Late deliveries from the Medical Depot.  
4.3.3.4.3 There is a poor communication amongst 
the role players. 
4.3.3.4.4 Lack of electronic ordering system.  
4.3.3.4.5 Duplication of patients. 
6
1
 
  
Category  Theme  Sub-theme  
4.3.3.4.6 Medicine Theft. 
4.3.3.4.7 Transport. 
4.3.3.4.8 Department Red Tape.  
4.3.6 Factors affecting the availability of 
medicines positively  
 
4.3.3.5 Certain factors promote the availability 
of medicines  
4.3.3.5.1 There is a strong Pharmaceutical Services 
Unit in the Free State at the Corporate 
Office. 
4.3.3.5.2 Partnerships with the private sector. 
4.3.3.5.3 The Medical Depot is running more 
smoothly, especially regarding emergency 
orders. 
4.3.7 Availability of medicines impact 
on service delivery  
4.3.3.6 Non-availability of medicine is negative 
towards patient care outcomes  
4.3.3.6.1 Medicine shortages definitely affect 
department reputation and patient 
wellbeing. 
4.3.3.6.2. The quality of work life for frontline workers 
is adversely affected. 
4.3.8 Essential medicine should be 
available at all times in the 
facilities  
4.3.3.8 Suggestions for improving medicine 
availability in the Free State District 
Health Services 
4.3.3.8.1 The Medical Depot should supply what is 
ordered. 
 
4.3.3.8.2 There should be experienced people and 
pharmacists’ assistants at the clinics. 
 
4.3.3.8.3 The Medical Depot and Pharmaceutical 
Services should be one department. 
 
4.3.3.8.4 Invest in an IT system for medicine stock 
management. 
 
4.3.3.8.5 There should be a proper Service Level 
Agreement with the Medical Depot.  
 
6
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Category  Theme  Sub-theme  
4.3.3.8.6 Establish a Mini Depot in each district.  
 
4.3.3.8.7 Teamwork and communication should be 
improved. 
 
4.3.3.8.8 There should be regular meetings between 
the role players. 
 
4.3.3.8.9 Reduce red tape in the procurement of 
medicines. 
 
4.3.3.8.10 Managers need to be empowered to 
manage medicine supply. 
6
3
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4.3.3 Discussion of themes and categories  
 
The central theme emerging is that medicines are often not available as required due to 
various factors.  
 
4.3.3.1 Medicine availability is understood differently in practice  
 
Medicine availability was understood differently by the participants. Some used the 
supplier, the management or the user perspective.  
 
4.3.3.1.1 All patients receive all the medications they need 
 
The management group regarded medicine to be available when the patients receive 
the prescribed medication on the day of the visit. The pharmacists also regarded 
medicine to be available when all patients receive all the medications they need as 
evidenced by the fact that all medicinal items on a prescription are issued to the patient 
at the time of visit at the facility, in the correct dosage, the correct strength, the correct 
quantities and at the correct storage conditions. 
 
One participant explained: “When no patient has to return home without receiving 
medication, then the medication is available”. 
 
This understanding is in line with the WHO standard that states that medicine is 
regarded as being available when the essential medicines required to treat the majority 
of conditions prevalent in that particular country is available at all times (WHO 2011a:2). 
The same standard was adopted by South Africa in 1996 as part of the introduction of 
the National Drug Policy (South Africa 1996:3). Another similar perspective in terms of 
facilities assessments is that medicinal items are considered to be available when at 
least one unexpired item is in stock (Pure Health Consulting 2012:97). The implication 
of this definition is that if more than one patient is prescribed the same medication, the 
other presenting patients may not receive medicine whilst awaiting delivery from the 
Medical Depot or higher levels of care as certain medicines require higher level 
authorisation by medical specialists. 
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4.3.3.1.2 From the Medical Depot's side medicine is sufficiently available when they 
can satisfy 100% of the demand of the health facilities   
 
The participants from the Medical Depot regarded medicine to be sufficiently available 
when the depot can satisfy 100% of the demand from the institutions. The Medical 
Depot medicine stock is kept and issued in accordance with the Free State Code List 
and the National Essential Drug List. 
 
4.3.3.1.3 The availability should be in line with provincial set norms and standards  
 
The department stipulated that medicine availability should be at least at 95% for 
essential medicines, including the following critical medicinal items: chronic treatment 
(diabetes, asthma, and hypertension), immunisation vaccines, antiretrovirals and 
tuberculosis medication, because these medicines are used by the majority of the 
population and are important for the preservation of human life (FSDOH 2012b:72).The 
provincial set medicine availability norm of at least 95% availability at all times was due 
to the impact of supplier challenges and stock outs from the Medical Depot. There was 
also an argument against this norm as explained in the following quote from one of the 
participants: 
 
"There will be difference in available medicines between facilities depending on what 
items are in demand. So the denominator differs from each and every facility but the 
Auditor General’s people couldn’t understand the principle and the result was the 
introduction of a common denominator based on the list drawn from the National Core 
Standards which include all the TB medication, the ARVs, the vaccines and a list of 
medicine items that was identified by National Department of Health. Now we report 
only on that and it doesn’t reflect everything. There are lots of items currently that are 
not on that list which is critical and which the people cannot get." 
 
The average of 95 % was accepted as a provincial norm as the majority of participants 
agreed that:  
 
“Certain medicines are not available due to supplier challenges which are not 
within the control of the department. As such these shortages should not be 
blamed to the department.”  
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The provincial target remains below the international and national norm of 100% 
availability of essential medicines, as according to the WHO medicine is regarded as 
being available when the essential medicines required to treat the majority of conditions 
prevalent in that particular country is available at all times (WHO 2011a:2). The same 
definition was adopted by South Africa in 1996 as part of the introduction of the National 
Drug Policy (South Africa 1996:3).  
 
4.3.3.2 Medicine availability differs in each district  
 
The availability for the year ending March 2011 was as follows in the different districts 
(see Table 4.3). Thabo Mofutsanyana, as the biggest and furthest district from the Main 
Depot in Bloemfontein, had the worst medicine availability followed by the 
Lejweleputswa district. The factors provided as affecting the availability in the various 
districts were the following: inconsistent availability of transport from the Medical Depot, 
inadequate availability of pharmacists to continuously facilitate placement, follow up and 
monitoring of stock levels, storage space for buffer stock and poor ordering patterns 
from the facilities. 
 
Motheo and Xhariep districts had better situations than the other three districts. The 
contributing factors were reported to be the proximity of these districts to the Medical 
Depot making it possible for self-collection of medicines should the depot have transport 
challenges.  
 
The participants further highlighted the following: 
 
“The status of the medicine availability differs by level of care, namely primary 
health care clinics, community health centres and district hospitals in the districts, 
as the skills and knowledge of medicine supply management differs as well as 
the type of medicine to be available.”  
 
A South African Department of Health commissioned assessment in 2011 found that 
less than 60% score was achieved by the Free State Health facilities across all districts 
in relation to the medicine availability standard (HST 2013:16). In another study 
conducted in India medicine availability differed in the various districts due to various 
factors, including inefficient distribution systems, non-compliance to Essential Medicine 
  
67 
Lists, and financial constraints (Kotwani et al 2007:649). According to Strengthening 
Pharmaceutical Services (2008:40), in the Northern Cape Province, across all the 
districts, medicine stock out was a major problem and the main factors contributing to 
the stock outs were poor record keeping and stock level monitoring which is key for the 
availability of essential medicines. 
 
Table 4.3 Medicine availability in five districts 2011 
 
District  % Availability 
Motheo  93 
Xhariep  94 
Thabo Mofutsanyana 81 
Fezile Dabi  92 
Lejweleputswa  87 
 
4.3.3.2.1 There is general acceptance that medicine availability in district hospitals is 
within the required standards  
 
Free State Hospitals have mostly maintained an average 95% stock level due to 
continuous availability of pharmacists and pharmacists’ assistants, as they are 
specifically appointed for medicine supply management and are competent in 
monitoring medicine stock levels and forecast medicine needs ahead of time. 
 
The participants argued that: 
 
“… [H]ospitals have pharmacists and the pharmacists are better at monitoring 
stock levels and planning ahead…’’.  
 
When probed about failure to ensure 100% availability the response was that the 5% 
shortage was contributed to by expired contracts for some medicines and the long 
process of obtaining specialist medicines that need to be ordered once prescribed as it 
is not normally kept at district hospital level.  
 
In the Northern Cape Province the non-availability of essential medicines in hospitals 
ranged from 3% to 45% which was far lower than in the Free State province. The 
hospitals had inadequate availability of pharmacists and pharmacists’ assistants for 
effective   medicine supply management, as well as poor stock management systems 
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and inadequate distribution transport availability (Strengthening Pharmaceutical 
Services 2008:38). 
 
4.3.3.2.2 The medicine availability in Community Health Centres is below the 
acceptable standards 
 
The Free State has 9 CHCs which have, on average, all maintained at least 90% stock 
level against a benchmark of 95%. The availability is also impacted positively by the 
availability of pharmacists and pharmacists’ assistants at this level. However, the high 
turnover of pharmacists as community services is completed and arrival of new 
pharmacists not knowing the ordering system contributed to the inadequate availability 
of medicines. 
 
"But just to also elaborate, as well you know, like he has indicated, we have been 
over 90%. But now for me in the beginning of the year especially when we have 
community pharmacists that are leaving and we have new people coming in we 
will experience problems in terms of medicine unavailability, because you have 
got new people who do not know the systems in government, so there will be 
challenges.” 
 
The literature review reveals that, in the neighbouring province of Northern Cape CHCs, 
the non-availability ranged between 10% and 64%. The major contributing factors are 
the total non-existence of pharmacists’ assistants and pharmacists in all CHCs and poor 
stock management practices, as nurses are responsible for stock management and 
ordering in addition to their routine nursing functions (Strengthening Pharmaceutical 
Services 2008:14). These factors affected medicine availability negatively.  
 
4.3.3.2.3 The medicine availability in primary health clinics is far below the required 
standards 
 
The Free State has 222 clinics run by professional nurses and varied availability of 
pharmacists’ assistants. There is also total lack of technology and electronic systems to 
facilitate orders. Medicine ordering and stock control is a manual process and, 
furthermore, some clinics do not even have telephones to follow up on orders. Medicine 
availability has been on average between 75% and 95%. The sub optimum availability 
is due to insufficient availability of pharmacists’ assistants and inconsistent ordering and 
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stock level monitoring at the clinics, as the professional nurses have other duties to 
execute rather than focusing exclusively on medicines supply management. 
 
The participants shared the following experiences with regard to primary health care: 
 
“You know with the clinics actually I have operational managers, but because of 
shortage of operational managers they are not primarily focusing on 
administration, including the medicine management. So there’s no-one dedicated 
for that. The very clinic manager starts readily with patient care, so medication 
should lie there unopened and at the time they’re susceptible to unlawful 
elements.” 
 
"Not all of them have pharmacists’ assistants. And you know what at times 
happen? You are waiting for the order at the district office, you phone the clinic. 
They just go and get last month’s copy and submit it because there is nobody to 
do the order at the clinic level then they just give it to you and because of 
experience you have been working with these people at times you will ask 
yourself but last month you ordered this much of this why are you ordering it 
again? Or at times you know this person is ordering only 20 Panado but that 
clinic can’t use 20 Panado a month. Then you make the necessary adjustment; 
where you’re not sure, you phone them. I am just trying to emphasise what she is 
saying when she says Human Resources is a big problem in our facilities really." 
 
“Lack of the monitoring system, long chain of order processing via the district 
office, lack of delegations for the clinic managers and delayed deliveries from the 
Medical Depot also contribute factors to inadequate medicine availability at the 
primary health care level.” 
 
Poor stock control and ineffective management of medicine and medical consumables 
occur despite these items being the second largest expenditure item in the health 
system after staff. It is accepted that the reason therefore is the insufficient availability of 
pharmacists and pharmacists’ assistants to manage the medicine supply chain at 
Primary Health Care level (NDOH 2011:68). Matse (2006:52) finds that an average out 
of stock of tracer (essential) medicines in the Mopani District PHC facilities exists. 
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The inadequate stock level monitoring system, long chain of order processing via the 
district offices, and lack of delegation coupled with no insight into budget allocated for 
medicines by the clinic managers, and delayed deliveries from the warehouses were 
cited as contributing factors to inadequate medicine availability at the primary health 
care level. Baloyi (2009:94) reports that a shortage of medicine in primary health care 
seriously affects service delivery. Patients become disappointed and lose confidence in 
the health services. Thus treatment outcomes are adversely affected and the staff 
morale is lowered. The non-availability of pharmacy personnel in primary health care, 
poor stock control and electronic drug supply management systems and lack of financial 
delegations are cited as the factors affecting the availability of medicine (Strengthening 
Pharmaceutical Services 2008:42).  
 
Another study also found that the factors contributing to low availability, especially in the 
clinic setting, include poor stock control and management in nurse led primary health 
clinics, and lack of pharmacists’ assistants to take charge of drug supply management. 
Lack of an electronic stock management system also played a role as the manual stock 
card was found not updated in most facilities (Pure Health Consulting 2012:97). 
 
4.3.3.3 Certain medicines should always be available  
 
In a narrative questionnaire completed by all participants at the beginning of the 
interviews the following medicines were mostly regarded to be important for consistent 
availability: tuberculosis medication, Antiretroviral, medication for chronic diseases, and 
vaccines.  
 
4.3.3.3.1 Tuberculosis  
 
Almost all the participants reported that TB medication at times was out of stock due to 
supplier challenges, resulting in the patients defaulting on treatment and becoming 
exposed to the potential of developing Extreme Drug Resistant TB. Pure Health 
Consulting (2012:97) reported that TB medicine availability was less than 100% in six of 
the seven provinces assessed. The factors identified were poor stock control in the 
primary health clinics and CHCs, in particular due to insufficient availability of pharmacy 
personnel, manual ordering, poor stock availability reporting, and also supplier 
challenges (Pure Health Consulting 2012:122). A survey conducted in a province in 
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South Africa reported that 22% of facilities reported that they were completely unable to 
provide paediatric TB treatments, often for many months, and in many cases this was 
an on-going problem.  
 
This was confirmed by the Depot’s order data, which showed that large volumes of 
paediatric TB treatments had not yet been received by the Depot and have in turn not 
been supplied to facilities in need, with 20 facilities still having outstanding orders at the 
time of this report. Long interruptions of TB treatment in children are likely to have a 
much higher proportional impact on mortality of these children than short interruptions of 
ART (Medicins Sans et al 2013:11). 
 
4.3.3.3.2 Antiretrovirals  
 
All participants reported the antiretrovirals to be out of stock periodically due to supplier 
problems as well as non-payment of accounts by the department, leading to suppliers 
withholding orders and thus affecting the availability of medicines.  
 
Pure Health Consulting (2012:97) also reported that ARV medicine availability was less 
than 100% in six of the seven provinces assessed. Western Cape was the only province 
with 100% availability for both ARVs and TB medicines. The challenge identified for 
ARVs was mainly poor stock holding capacity and supplier stock shortages due to poor 
estimation of drug needs. MSF and TAC reports are based on a survey of 72 health 
facilities supplied by the Mthatha Depot to establish whether they had experienced 
stock outs during the period of September 2012-January 2013. The survey found that 
24% of those facilities surveyed had to send away more than one regular ARV 
dependent patient without treatment. Had drug supply not been re-established this 
situation would have quickly deteriorated further, with 53% of facilities surveyed also 
reporting stock outs of one or more HIV or TB medicines (Medicins Sans Frontiers et al 
2013:11). 
 
4.3.3.3.3 Vaccines  
 
The majority of participants also reported vaccines to be frequently out of stock, 
especially during the campaign period. This occurrence is regarded as problematic as 
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the prevention of communicable diseases through vaccination is essential to reduce the 
infant mortality and morbidity prevalence in the country.  
 
One pharmacist emphasised:  
 
“We cannot be without our vaccines so we must have overall 100%’’. 
 
An investigation by Section 27 in the Gauteng Province found that there were shortages 
of the 5 in 1 vaccine, Rotavirus-, and Pneumococcal Vaccine, which are key to the 
implementation of the Expanded Programme of Immunisation for reduction of child 
mortality from communicable diseases (Section 27 2013:12). 
 
4.3.3.3.4 Chronic diseases medicines  
 
All participants reported that certain chronic medicines are always out of stock in 
practice due to supplier challenges, Medical Depots’ insufficient stock as well as poor 
ordering practices in the facilities. 
 
“Even though some medicines may almost always be available the lack of critical 
items such as Metformin, a diabetic medicine, may cause big problems, due to it 
being critical items for management of diabetes.’’ 
 
In a survey of 40 countries equitable and regular access to essential medicines for 
chronic disease was reported to be worse than that of acute medicines as the 
availability was only 36% and 54.7% respectively. Low public sector availability of 
essential medicines is often caused by a lack of public resources or under-budgeting, 
inaccurate demand forecasting, and inefficient procurement and distribution (World 
Health Organization 2011 b: 1. In another study the availability of certain key medicines 
used for chronic diseases was reported to be poor in several countries. 
Hydrochlorothiazide, a tablet used for the management of hypertension, had poor 
availability in the public sector in Bangladesh and in both the public and private sectors 
in Nepal and Pakistan. Both ACE inhibitors and statins have been shown to prevent 
recurrent attacks in patients with coronary heart disease and are important for 
secondary prevention. However, the availability of ACE inhibitors was poor in the public 
sector in Bangladesh and Malawi and in both sectors in Nepal (World Health 
Organization 2007). The availability of treatment for diabetes was also reported            
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to be low in 12 districts of India. The worst off district indicated that only one out of 26 
facilities had stock of glibenclamide (Kotwani et al 2007:649). 
 
In summary, the participants unanimously identified the medicines for management of 
tuberculosis, AIDS, chronic conditions including diabetes, hypertension, asthma and the 
immunisations as the medicines that should always available. These were regarded as 
important because these are the medicines required by the majority of the population 
and are used in the prevention as well as treatment of priority diseases in the country. 
These medicines also fall under the Primary Health Care Essential Medicine List for 
South Africa. The National Department of Health has also regarded these medicines as 
part of the non-negotiable items for consistent availability (NDOH 2008:6). 
 
4.3.3.4 Certain factors negatively affect the availability of medicines   
  
4.3.3.4.1 Poor medicine stock management 
 
The participants reported delayed ordering and monitoring of the stock levels, especially 
in primary health clinics, as the majors factor affecting the availability of medicine. 
Professional nurses were reported to generally not prioritise medicine ordering and 
control, but rather to focus on core patient care duties. 
 
The participants highlighted the following practical experiences with regard to poor 
medicine stock management: 
 
“The stock cards are also generally not updated to identify the ordering 
requirements. The clinic personnel in some instances dispense medicine to the 
last unit before placing an order. In such situations the likelihood of stock out is 
high as the standard lead time for medicine to arrive at the facility is six weeks 
from the date of placing the order. However, in practice this takes 6–12 weeks on 
average”  
 
"Not all of them have pharmacists’ assistants. And you know what at times 
happen?  You are waiting for the order at the district office, you phone the clinic. 
They just go and get last month’s copy and submit it because there is nobody to 
do the order at the clinic level then they just give it to you and because of 
experience you have been working with these people at times you will ask 
yourself but last month you ordered this much of this why are you ordering it 
again or at times you know this person is ordering only 20 Panado but that clinic 
can’t use 20 Panado a month. Then you make the necessary adjustment; where 
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you’re not sure, you phone them. I am just trying to emphasise what she is saying 
when she says Human Resources is a big problem in our facilities really." 
 
“At the end of the year there are problems with medication availability because 
the systems close, the managers often over-stock just before the system closes. 
However, sometimes the bulk medicine that is ordered is not managed correctly 
and end up expiring in the shelves.” 
 
According to a study conducted on drug shortages in the Mopani district of the Limpopo  
Province, the poor quantification practices by the primary health care staff contributed 
medicine being unavailable as personnel would order medicine without regard for 
minimum and maximum stock levels required for the facility (Matse 2006:52). 
 
Another review of drug management and procurement practices conducted in the period 
2006-2007 at the Kilembe Hospital in the Kasese District revealed that there were 
frequent medicine stock outs in the health units ranging between 24 and 94 average 
days.  
 
In addition, large quantities of expired medicines were found in most district level 
facilities. The factors contributing to this situation were the irrational procurement and 
provision of medicines not based on needs and requisition, and poor quantification and 
donor driven supplies without proper coordination with the recipient department to 
determine actual need. These practices led to non-availability of essential medicines 
required for treatment of prevailing conditions, including malaria and sexually 
transmitted diseases (Tumwine et al 2010:559). 
 
Furthermore, according to Pure Health Consulting (2012:97), the factors contributing to 
the low availability of medicines, especially in the clinic setting, also include poor stock 
control and management in nurse led primary health clinics, lack of pharmacists’ 
assistants to take charge of drug supply management, and lack of electronic stock 
management systems (the manual stock card was found not updated in most facilities).  
 
The insufficient availability of pharmacy personnel in the public health system is 
reported to be amongst the contributing factors in the non-availability of medicines in 
district health services as nursing personnel tend to prioritise the service delivery and 
lag behind with consistent ordering of replacement medicine stock as well as following 
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up on placed orders for uninterrupted supply and availability of medicines 
(Strengthening Pharmaceutical Services 2008:29). 
 
4.3.3.4.2 Late deliveries from the Medical Depot  
 
The Medical Depot does not always comply with the schedule of the deliveries due to 
medicine suppliers’ contracts not being in place as well as challenges with the 
distribution company for delivery of medicines. The participants mentioned the following: 
 
“The delayed deliveries occur definitely from the beginning of the year, and also 
towards the end of the financial year when there are all these processes that 
have to happen towards the end of the financial year leading to the beginning of 
the financial year where now the budget has to be captured. During these times 
you can't do anything including placing of orders due to stocktaking, closing of 
books and all those kinds of things."  
 
"The Medical Depot is also affected by the time taken to finalise contracts. You 
will find that the contract is expiring end of August. It means that national treasury 
needs to see to it that before the contract expires they re-negotiate whatever they 
want to negotiate to ensure that come the 1st of September that contract is 
ready. Most of the time there is a break in between. After the contracts have 
expired they are still negotiating the new contracts, and you cannot procure from 
the expired contracts. Now you have to buy on quotation then there comes the 
supply chain processes that you need to follow which contribute to further delays. 
By the time we get the medication it could be two to three months later." 
 
The suppliers in some instances fail to provide the complete order citing reasons of 
inconsistent supplies from the manufacturers. Often managers are told that the 
medication is not available anywhere, not even at national level, and the national 
treasury is also sometimes unresponsive. The supply chain refuses certain suppliers. 
 
In Sudan availability of essential medicines was found to be relatively higher in medical 
stores and private pharmacies with the average availability reported at 100%. However, 
there was low availability in the public facilities with the average being 82%. Public 
health facilities experienced lower availability of medicine due to the absence of 
medicine inventory cards, poor financial support for transportation, and distribution from 
the central medicine store to the pharmacies (Elamin et al 2010:36). 
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4.3.3.4.3 Poor communication amongst the role players 
 
Medicine was reported to be available at times in the Medical Depot but not at the 
facilities. Communication was cited as the factor in this situation despite availability of 
standard operating procedures stating the communication channels and platforms.  
 
“There is a communication problem with suppliers and the communication 
between the District pharmacists and Medical Depots is also not always up to 
standard”. 
 
“In the beginning of the year especially when we have community pharmacists 
that are leaving and we have new people coming in we will experience problems 
in terms of medicine non-availability because you’ve got new people who don't 
know the systems in government so there will be challenges.” 
 
Improved communication through involvement of all role-players in medicine stock 
management including finance, programme managers, and pharmacists, and the 
adjustment of issuing quantities during limited stock periods were found to be a positive 
contributory factor in above average medicine availability in the North West and 
Western Cape (Pure Health Consulting 2012:129). 
 
Lack of communication between the Medical Depot and health facilities, especially in 
terms of stock availability, was noticeable in the provinces with low medicine availability. 
The contributory factors were the lack of telephone, fax, internet and stationery 
(Strengthening Pharmaceutical Services 2008:39). 
 
4.3.3.4.4 Lack of electronic ordering system  
 
The Free State province as a whole does not have an electronic medicine supply, 
monitoring and ordering system in order to monitor stock levels and automatically 
generate orders when the ordering level is reached. The district pharmacists and the 
Medical Depot depend on the end users to submit medicine needs manually. This can 
take time and orders are placed once a month or even every second month. There is a 
high likelihood that those facilities that do not order consistently will not have medicine, 
but also that other facilities could be overstocked whilst another facility in the same area 
is under stocked due to lack of electronic monitoring systems. 
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“The clinics often have trouble to stay in contact with other facilities due to 
resource challenges. Often the clinics do not have computers and are not 
connected in terms of internet. It would be much easier for communication if all 
facilities were linked on one system.” 
 
If the province had an electronic medicine management system the above bottlenecks 
could have been eliminated. Resources like photocopies machines and fax equipment 
are also important, but often not available to transfer orders through.  
 
An efficient and computerised central purchasing system is highly recommended to 
improve medicine availability in the public sector. Western Cape and North West had 
above 95% availability. The factors that contributed to this include electronic stock 
management, close monitoring and weekly reporting on stock availability (Pure Health 
Consulting 2012:129). With regard to the use of computer or stock cards to monitor 
stock movements only 52% used stock cards or requisition forms. None used a 
computer system. The absence of these tools which play a role in ordering and 
monitoring of stock could explain why some facilities did not have stock - because they 
were ordering without any reference. Orders were placed arbitrarily or based on 
experience. It was expected of all of them to have either a computer system or non-
computerised tools such as stock cards in place (Strengthening Pharmaceutical 
Services 2008:39). Successful computerisation of medicine supply management can 
greatly increase an organisation efficiency and capability for ensuring consistent 
medicine availability (MSH 2012:50:18). 
 
4.3.3.4.5 Duplication of patients 
 
The patients were said to occasionally visit a number of clinics for the same condition 
without allowing the prescribed treatment to take effect.  
 
“This also happens with regards to patients who are applying for government 
grants, these people visit the clinic on a very regular basis thinking that they will 
be regarded as chronic patients so that the doctors will approve the person's 
application for a grant.” 
 
“One person visits more than one clinic for the same medication. This happens 
especially with contraception and people coming from neighbouring countries. 
She goes to this clinic they give 3 packets and to the next clinic for another 3 
packets.” 
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"The other thing is with us it happens because our clinics are nurse-driven but 
sometimes the doctors are there so patients prefer to see a doctor rather than a 
nurse. At times the patient is honestly sick and is seen by a professional nurse 
the following day the same patient goes to clinic B because they know the doctor 
is there and they get duplication of medicines.” 
 
Furthermore, people may prefer to be examined by a specific person at the institution as 
explained below: 
 
“I don’t like sister A, I like sister B and would go today and then I would tell her 
that I was here yesterday but I feel that I prefer to be seen by you, the patients 
also at times do not trust the changing of medication packaging and colour of 
medicines due to different suppliers and would visit different clinics until she finds 
the regular packaged medicine.” 
 
The increase in the numbers of patients visiting primary health care due to health policy 
changes post democratic government - which classified primary health services as free 
– and the medicine shopping behaviour by the patients visiting more than one facility 
without allowing the original prescription to take effect was reported to also have had a 
role in the Limpopo province’s non-availability of medicine (Baloyi 2009:28). 
 
4.3.3.4.6 Medicine Theft  
 
A few incidences of medicine theft have been reported in the districts. 
 
“The depot will deliver and then the stock will be lying in the corridors or in the 
passages – that also affects the depot, because say for instance the depot 
delivers 10 boxes and then they don’t have time to look into the contents and 
then after 5 days they will phone and say, “we are short of this”. And we can’t 
prove; because also from the depot, our systems are not actually 100%. 
Everything is done manually. So if they say they are short of the delivered stock 
we normally give them 48 hours to report. Often after the delivery, shortages are 
reported to the Medical Depot without any proof.” 
 
“In a clinic there was this sister who was caught with boxes of medication”. 
 
It has been established in Nigeria that a significant proportion of essential medicines 
meant for the Primary Health Care are misappropriated or diverted. Health workers, 
especially the storekeepers and those at the dispensaries, are said to divert some of the 
items either for personal use or theft (Ohuabunnwa 2008:7). Another confirmation of 
possible leakages and theft of medicines in the health facilities was the acceptance and 
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prevalence of inadequate management, security, and controls in KwaZulu-Natal’s 
Pharmaceutical Services leading to increased risk of leakage and theft. The situation is 
made worse by the inadequate availability of experienced pharmacists in the facilities 
resulting in junior personnel, often Community Service Pharmacists, running the 
pharmacies (KZNDOH 2012:44). 
 
4.3.3.4.7 Transport 
 
The delivery of medicine to the facilities is the responsibility of the Medical Depot and 
has been outsourced to a private company. The transportation of medicines is not 
without challenges as mentioned below: 
 
“The delivery company has to deliver to all (262) facilities at least once a month 
sometimes not often, it happens that when it snows or rains the truck cannot 
reach a facility also the road infrastructure provides a challenge as the roads may 
not be very accessible in that case the medicine is delivered to the nearest 
hospital and the clinics have to collect it from the hospitals.” 
 
The participants also mentioned that there are instances where the Medical Depot has 
medicine in stock, but is unable to deliver due to transport problems as well as delayed 
delivery schedule and the fact that the districts do not have the suitable vehicles to 
collect medicines directly. 
 
“Sometimes medicine cannot be moved between clinics due to transport 
problems, which cause a big problem.” 
 
Inefficient transport and distribution systems was reported as one of the factors leading 
to frequent stock outs in India (Kotwani et al 2007:652). In a study by Strengthening 
Pharmaceutical Services (2008:37) it was reported that, although there was a delivery 
roster at the depot, the transport of medicine from the depot to the districts and within 
the districts to clinics appeared to be a challenge. In the districts there was no dedicated 
means of transport to deliver medicine from hospitals to clinics. In most instances 
medicines were delivered through patient transport and ambulance or staff’s own 
transport with serious implications on the lead times. Outsourced transportation of 
medicines can promote better, cheaper and efficient delivery of medicines than that 
which government services are able to provide (MSH 2011:25:14).  
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4.3.3.4.8 Department Red Tape  
 
The participants felt that medicine availability is also affected by the red tape and lack of 
delegation by the facility managers to authorise orders at the facility level. The view was 
that the availability could be improved if the department could reduce the red tape and 
long processes by allowing the clinic managers to authorise orders for medicines at 
facility level.  
 
"I have seen in the department that the most problems are created by top 
management through the red tape.” 
 
There was also the view that the managers’ inefficiencies make it necessary to 
introduce red tape in the organisation. One participant put it:  
 
“Sometimes we are creating our own red tape ourselves, but not always. The way 
we operate we tend to create that tape ourselves. I mean if I don't manage the 
budget of the clinic quite correctly, someone sitting at head office all he sees is 
this budget cannot be managed at that level. Then he or she takes that 
responsibility. But if it is done correctly at the facility level, someone at head office 
or someone out there can have confidence on that particular person. So this 
person is responsible and accountable enough to take this type of responsibility.” 
 
The pharmacist participants felt that the tender processes were also to be blamed for 
the non-availability as mentioned in the following excerpt: 
 
“And the other thing is the tender processes – the province forces us to procure 
70% from Small Micro and Medium Enterprises (SMME) meaning that we should 
upgrade or advance the SMMEs. They tell us we need to have 70% of the money 
spent within the Free State; however we don’t have the companies that are 
manufacturing the medicines in the province. And then they force us 
(pharmacists) to buy from the people that are not registered knowing that you are 
not going to get the required supplies from them, so it’s really a struggle for 
medicines procurement, for the medical supplies may be you can buy a Band-Aid 
and if not usable you’ll throw it away but with the medicines you cannot. Maybe 
the government should start looking at the tender process before we can go 
anywhere.” 
 
In 2008 Kangwana et al. (2009:737), in a study conducted to investigate the availability 
of malaria medication in government facilities, found that 25,6% of the surveyed 
facilities did not have any of the four treatment packs in stock. The factors contributing 
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to this stock out were mainly due to procurement failures and delays due to shift from 
direct procurement to open tender processes which was intended to achieve value for 
money and increase competition.  
 
4.3.3.5 Certain factors promote the availability of medicines   
 
4.3.3.5.1 There is a strong Pharmaceutical Services Unit in the Free State at the 
Corporate Office 
 
The pharmacists reported that there is a strong Pharmaceutical Services office in the 
Free State at the Corporate Office. This office provides support and assists facilities by 
ensuring that medicine is available through various means, including movement of stock 
from facilities with surplus to those with deficits. 
 
“For me I think the Pharmaceutical Service in the province, is at least recognised 
by our seniors when we can at least be called by HOD to come and discuss 
medicine provisioning problems. It means there’s recognition of this service which 
was not there before and I think there is an impact on getting things. They 
understand where we are coming from, they can assist us. We have our strong 
Pharmaceutical Services Office, we are getting there.” 
 
The Pharmaceutical Services office is also responsible for policy formulation, oversight 
and coordination of the Pharmaco Therapeutic Committee (PTC) which contributes 
positively towards addressing all problems encountered as well as improves availability 
of medicines. 
 
“The functionality of our PTC does contribute positively towards addressing all 
these problems.” 
 
The hosting of regular meetings with key stakeholders is said to have a positive 
influence on the availability of medicines.  
 
“The regular meetings on Drug (Medicine) Supply Management and District 
Pharmacists facilitated by the Pharmaceutical Services office also assists to 
enhance medicine availability as in these meetings the pharmacists can share 
information on the challenges and updates from the pharmaceutical companies 
with regard to medicine availability.” 
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Effective management and good governance through oversight and advocacy by the 
policy  units  make a vital difference in all aspects of medicine supply management 
especially in procurement and distribution of essential medicines (MSH 2011:1:10). 
 
4.3.3.5.2 Partnerships with the private sector  
 
The province is supported by Management Sciences for Health to promote effective 
management of medicine through initiatives including implementation of electronic 
ordering system, improvement of the operations at the Medical Depot and development 
of the Service Level Agreement between facilities and the Medical Depot. 
 
“Also our partnerships with private sector like MSH – Management Sciences for 
Health - they actually contribute very positively in us rendering the services to our 
people.” 
 
Partnerships have the potential, if well managed, to provide effective technical support 
to countries through capacity building, management information systems, procurement, 
distribution, storage, development of quality assurance systems, medicine financing, 
and information sharing (WHOAFRICA 2006:13). 
 
4.3.3.5.3 The Medical Depot is running more smoothly especially regarding emergency 
orders 
 
The communication and service at the Medical Depot has improved. With the 
appointment of the new pharmaceutical manager at the Medical Depot the pharmacist 
group reported that there is improved communication and provision of assistance, 
especially for emergencies and bail-outs of struggling facilities with the orders and 
medicine stock out situation.  
 
“At the Medical Depot now, I think things are beginning to run smoothly even with 
the emergency orders. The last time I was at the Medical Depot for emergency 
orders was I think 3 months back.” 
 
Another participant added:  
 
“I am going today again today so that means really they are doing a wonderful 
job. Even with the enquiry of the ARVs side, I don't know if that is because I am 
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here in Bloemfontein I just phone and say you didn't deliver Stavudine, I want 
Stavudine and they say ok after 2 hours they call me come and get it so I think 
the situation has improved a lot at the Medical Depot.” 
 
Medical Depot efficiency is key in the consistent availability of medicines as was 
observed in the Northern Cape where inefficiencies led to poor availability of medicines 
in the facilities. The Medical Depot plays a critical role in the selection, purchase, 
storage, and distribution of medicines and other medical devices in the province 
(Strengthening Pharmaceutical Services 2008:41).  
 
4.3.3.6 Non-availability of medicine is negative towards patient care outcomes 
 
4.3.3.6.1 Medicine shortages definitely affect department reputation and patient 
wellbeing 
 
All participants agreed that when patients arrive at the facility and do not receive the 
required medicine they lose trust and confidence on the ability of the department to 
deliver on the constitutional mandate to deliver quality health services. Health Service 
Delivery is negatively affected as the patient defaults on treatment. Some develop 
resistance to first line treatment leading to disease complications that require expensive 
regimens and possible hospital admissions. 
 
“Service delivery gets affected negatively when we’ve got shortages, because 
people then do not have trust in us.” 
 
“As a department we have taken a conscious decision that we shouldn’t be 
running short of medicines – it’s an embarrassment.”  
 
Medicine availability affects the productivity as when medicines fail to arrive, health 
programmes’ effectiveness is constrained and health workers are disabled from 
delivering a quality service (MSH 2011:1:4). 
 
4.3.3.6.2 The quality of work life for frontline workers is adversely affected  
  
The frontline staff faces abuse and humiliation by the disgruntled patients who do not 
understand the processes and delays in the delivery of medicines for dispensing to the 
patient. A lot of time is wasted on phoning, planning and transport arrangements. 
  
84 
“Ja, it's very de-motivating because you go to work, I am going to do this and that 
and that. This is my priority list today now suddenly they phone you and they tell 
you nobody has got Cidex. Now you must do something about it the whole 
province is looking at you and you spend the whole day just trying to solve that 
one problem. At the end of the day you didn't solve the problem because there 
was nobody that could help you. You phoned National Department of Health you 
tried all the other provinces and tried to borrow from them you tried to get another 
source and the people are not answering their phones it's really very 
demoralising.” 
 
“The inconvenience drains the persons responsible for trying to organise the 
medicine and make transport arrangements. The failure to deliver an optimum 
service is de-motivating to staff.” 
 
The credibility of health workers depends on the ability to provide relevant treatment for 
presenting complaint or symptom (MSH 2011:1:4). 
 
4.3.3.7 Suggestions for improving medicine availability in the Free State District 
Health Services 
 
The participants were asked to provide suggestions on how to improve medicine 
availability in the Free State specifically and reflected below are their views.  
 
4.3.3.7.1 The Medical Depot should supply what is ordered 
 
Both the managers and the pharmacists agreed that for consistent availability of 
medicines the Medical Depot should be able to meet the demands of the users all the 
time. This expectation requires that the depot should keep sufficient stock and buffer 
stock for all the essential and fast moving items to cover for delays in the deliveries from 
the suppliers. 
 
“I think my situation can only be improved if the Medical Depot supplies what I 
order.” 
 
4.3.3.7.2 There should be experienced people and pharmacists’ assistants at the 
clinics 
 
Having dedicated personnel in the form of pharmacists’ assistants focusing exclusively 
on medicines will ensure that medicine stock ordering and management is not a 
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secondary function of the professional nurses who may forget to place orders or rotate 
stock to prevent expiry of medicines. 
 
“What we’re trying to say is that at clinic level it’s very rare that you’ll have a 
pharmacist, whereas in hospital you probably will have a pharmacist and that will 
assist you for instance to know that at this point when I have this quantity of 
medicine I start my ordering process.” 
 
“Where there’s no pharmacy assistant it now becomes the responsibility of the 
sister in the clinic who has to see patients and do a whole lot of other things. So 
in the hospital you have somebody with much better skills to manage the 
medicine, a pharmacist but clinics may be relying on a district pharmacist or 
perhaps a pharmacy assistant. So those challenges then become evident in the 
availability of medicines in our facilities if you were to compare clinics, community 
health and district hospitals." 
 
4.3.3.7.3 The Medical Depot and Pharmaceutical Services should be one department 
 
The participants expressed the view that when the Medical Depot and Pharmaceutical 
Services were under one management the medicine availability was optimal; because 
the drug management cycle require that there should be synergy between medicine 
procurement and policy processes. 
 
“For me you need to have a depot together with pharmaceutical service it will be 
one thing to match. The depot falls under finance and for me it does not work for 
us.” 
 
4.3.3.7.4 Invest in IT system for medicine stock management 
 
Medicine availability is difficult to monitor from a central point without the availability of 
the electronic tracking system. The participants recommended that there should be an 
electronic medicine supply management system starting from the Medical Depot to all 
the health facilities to allow for monitoring of stock levels, ordering patterns, and expiry 
dates to prompt appropriate action including placing of orders on reaching the minimum 
stock levels. 
 
“If we could have electronic medicine management system for me in government 
we are still 15 years behind in terms of rendering service. I am talking here 
technology, especially when it comes to the clinics. What is preventing a patient 
to go to 20 different facilities and get the same type of medication? If we can 
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have a system that when the patient comes and gets medication you can pick it 
up. Some patients are just taking chances if we could have technologies installed 
in our facilities so that we can manage things better.” 
 
4.3.3.7.5 There should be a proper Service Level Agreement with the Medical Depot  
 
There should be clear responsibilities and penalties for all involved in the provision of 
medicines, especially the facilities management, who should ensure payment of the 
medicine account within 30 days to ensure that the depot has adequate cash reserves 
and can pay its suppliers on time, the Medical Depot should ensure that stock is 
available and delivered within the 6 week period of the placing of the order. This can 
only be achieved once the Service Level Agreement is approved and implemented in 
the province. 
 
“We sat for days developing a Service Level Agreement of the Medical Depot 
with the facilities. That must be signed and implemented and if it works it will be 
wonderful.” 
 
4.3.3.7.6 Establish a Mini Depot in each district  
 
The provision of medicines from one central depot was reported as one of the areas to 
be reviewed as the Free State province is wide and further apart. One recommendation 
was that there should be mini depot (warehouse with bulk stock from the main depot), at 
least one in each district, so that the medicine store is closer to the facilities thus 
reducing the long waiting period for deliveries. 
 
However, this proposal has the potential to increase staff and need of storage areas 
within the district. The consideration of this proposal should be accompanied by the cost 
benefit analysis. 
 
“If the implementation of the Service Level Agreement does not work we will have 
to look at establishing mini depots in our districts because we want supply of 
medication for every day.” 
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4.3.3.7.7 Teamwork and communication should be improved 
 
The medicine provision information originate from multiple sources namely the National 
Treasury for new tenders for medicines, the National Department of Health  for new 
protocols, and the various suppliers for the status of the availability from the 
manufacturers. As such continuous, effective communication and cooperation should 
exist amongst all stakeholders. 
 
Further, with the Pharmaceutical Services, health facilities and the Medical Depot 
located in various clusters there is a need for better, clearer communication and 
teamwork to ensure that medicine availability information reaches all key stakeholders 
on time to minimise interruptions and stock out in the facilities.  
 
“I think that everything will work if all of us work together and that we can be one 
team. You know currently we are really fragmented and there is not really 
communication.” 
 
4.3.3.7.8 There should be regular meetings between the role-players 
 
The Medical Depot should also engage the suppliers through standing meetings to 
address any bottlenecks that may occur at times impacting on medicine stock provision.  
 
The Medical Depot, facilities, supply chain, and Pharmaceutical Services should meet 
periodically for discussions, updates and resolutions of system red tape processes to 
address the challenges encountered by the facilities in the provision of medicines. 
 
“I think that everything will work if all of us work together and that we can be one 
team as they said. You know currently we are really fragmented and there is not 
really communication. And if we don't have meetings like this on a regular 
basis…there is nobody who can really take a decision.” 
 
4.3.3.7.9 Reduce red tape in the procurement of medicines 
 
Medicine orders are subject to departmental financial delegations resulting in orders 
from the clinics supposed to be authorised at district level thus delaying the finalisation 
of the order and delivery to the facilities. 
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“Further requirement by supply chain a unit for three quotations despite the 
particular medicine being available only from one supplier is time wasting and 
should be reviewed.” 
 
4.3.3.7.10 Managers need to be empowered to manage 
 
The clinic managers need to know their clinic budgets, costs of medicines, and be given 
the necessary delegation power to authorise the procurement of essential supplies 
including medicines.  
 
The clinic managers also need to be capacitated on medicine supply management 
including stock control and electronic ordering of medicines. 
 
“And managers need to be empowered to manage as cost centre managers to 
understand the implications of over-budgeting and under budgeting as well then 
be given chance to do their work as clinic administrators. Right now we don’t 
have dedicated administrators because of staff shortage.” 
 
4.4 CONCLUSION  
 
Based on the findings presented it is clear that medicines are not always available as 
required for optimum service delivery in health facilities. The non-availability of 
medicines has a negative impact on the department, staff, and the service users. The 
next chapter will present the recommendations and the conclusion for the study. 
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CHAPTER 5 
 
CONCLUSIONS AND RECOMMENDATIONS 
 
 
5.1 INTRODUCTION  
 
In this chapter the research findings, recommendations and conclusions will be 
presented. 
 
5.2 RESEARCH DESIGN AND METHOD  
 
5.2.1 Research purpose 
 
The purpose of the study was to investigate the factors affecting the availability of 
medicine in the various district health services in the Free State. 
 
5.2.2 Research objectives 
 
 Explore and describe the factors affecting the availability of medicine in the 
various district health services in the Free State. 
 Make recommendations on corrective measures to be implemented to improve 
the availability of medicine in the various district health services in the Free State. 
 
5.2.3 Research questions  
 
 What are the factors that contribute towards insufficient availability of medicine in 
the District Health Services in the Free State?  
 How can the Free State Department of Health ensure sufficient medicine 
availability in the District Health Services of the Free State? 
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5.2.4 Research design  
 
This research was conducted through experiences of the managers responsible for 
provision of medicines in the five districts. In this study the design used had to provide 
for in depth narratives and content rich data. It is for this reason that the qualitative 
exploratory, descriptive and contextual research design was chosen to allow for the 
respondents to share first-hand experience of the subject under investigation to produce 
quality research information. Welman et al (2005:8) recommend qualitative research 
designs for studies aiming to understand the significance which respondents attach to 
their environment as well as enabling the researcher to obtain deeper understanding of 
what is being investigated. Qualitative research involves several methods of data 
collection such as focus groups, field observation, in-depth interviews and case studies 
to obtain rich data (Wimmer & Dominick 2006:48). 
 
The method selected for this study was focus group discussions through in depth 
interviews with the participants to obtain a detailed explanation of the experiences in 
relation to medicine availability. 
 
The population for this study was the pharmaceutical managers and the district health 
services managers within the Free State province comprising of: 
 
 The seven pharmaceutical managers, including a responsible pharmacist for the 
Medical Depot, the Provincial Head of Pharmaceutical Services, and five district 
pharmacists representing each of the five districts.   
 The District Managers group inclusive of all five District Managers and the 
Manager of the Medical Depot who were all professional nurses by profession.   
 The core function of the study population is to ensure provision of quality health 
services and medicines to the Free State Communities within a district level 
setting.  
 
5.3 SUMMARY AND INTERPRETATION OF THE RESEARCH FINDINGS  
 
The research findings based on the data analysis indicate that medicines were not 
always available in the district health services, in particular at community health centres 
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and primary health clinics. District hospitals were found to have satisfactory medicine 
availability.  
 
The following factors affected negatively the availability of medicines: 
 
 Poor medicine stock management 
 Late deliveries from the Medical Depot 
 There is a poor communication amongst the role players 
 Lack of electronic ordering systems 
 Duplication of patients 
 Medicine theft 
 Transport 
 Departmental red tape 
 
Below is the summary of the key findings:  
 
5.3.1 Poor medicine stock management 
 
The study’s findings indicate that the inadequate availability of pharmacists and 
pharmacists’ assistants in clinics and community health centres resulted in poor 
medicine stock management as the professional nurses were unable to render health 
services whilst at the same time carrying out medicine ordering and stock control duties. 
It has been accepted that the reason therefore is insufficient availability of pharmacists 
and pharmacists’ assistants to manage the medicine supply chain at Primary Health 
Care level (NDOH 2011:68). 
 
Matse (2006:52) found that there were tracer medicine shortages in the Mopani 
District’s (Limpopo) PHC facilities. The inadequate stock level monitoring system, long 
chain of order processing via the district offices, and lack of delegation coupled with no 
insight into budget allocated for medicines by the clinic managers and delayed 
deliveries from the warehouses were cited as contributing factors to inadequate 
medicine availability at the primary health care level. Baloyi (2009:94) reported that 
shortage of medicine in primary health care seriously affects service delivery in that 
patients become disappointed and lose confidence in the health services, affecting 
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treatment outcomes adversely and lowering the staff morale. The non-availability of 
pharmacy personnel in the primary health care setting, poor stock control and lack of 
financial delegations were cited as factors affecting the availability of medicines 
(Strengthening Pharmaceutical Services 2008:42).  
 
Another study also found that the factors contributing to the low availability, especially in 
the clinic setting, include poor stock control and management in nurse-led primary 
health clinics, lack of pharmacists’ assistants to take charge of drug supply 
management (Pure Health Consulting 2012:97). In facilities where pharmacists and 
pharmacists’ assistants are employed there is generally adequate medicine availability. 
 
5.3.2 Late deliveries from the Medical Depot  
 
The delay in the delivery of ordered medicines was found to be due to various reasons, 
including medicine stock out at the Medical Depot caused by non-finalisation of 
medicine suppliers’ contracts, non-payment of the suppliers, as well as the distribution 
company contract and end of the year financial closures for stock take during which the 
Medical Depot does not handle orders or issue medicine to any facilities.  
 
Elamin et al (2010:36) reported that public health facilities were reported to experience 
less availability of medicines due to poor financial support for transportation and 
distribution from the central medicine store to the pharmacies. 
 
The delayed deliveries from the Medical Depot were reported to be due to poor human 
resources availability as well as closure for stocktaking purposes and failure of suppliers 
to meet the depot demands due to stock outs or inadequate tender processes leading to 
long delivery periods from the time of order by the facilities (Section 27 2012:21). 
 
5.3.3 Poor communication amongst the role players 
 
Medicine was reported to be available at times at the Medical Depot, but not at the 
facilities. Communication was cited as the main contributing factor to this situation 
despite the availability of standard operating procedures stating the communication 
channels and platforms to be used for medicine supply purposes. The problem of the 
lack of permanent pharmacists in district hospitals and community health centres in 
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particular leads to new community service pharmacists being placed in facilities with no 
knowledge and initial orientation on the procedures for ordering and communication 
systems of government. Lack of communication between the Medical Depot and health 
facilities, especially in terms of stock availability, was noticeable in provinces with low 
medicine availability (Strengthening Pharmaceutical Services 2008:39). Pure Health 
Consulting (2012:129) noted that improved communication through involvement of all 
role-players in medicine stock management including finance, programme managers 
and pharmacists, and adjustment of issuing quantities during limited stock period were 
positive contributory factors in above average medicine availability in the North West 
and Western Cape. 
 
5.3.4 Lack of electronic ordering systems  
 
The Free State Province as a whole does not have an electronic medicine supply, 
monitoring and ordering system to be able to monitor stock levels and automatically 
generate orders when the ordering level is reached.  
 
The district pharmacists and the Medical Depot depend on the end users to submit 
medicine needs manually. This can take time as orders are placed once in a month or 
even every second month. 
 
The lack of the electronic ordering and monitoring systems increase the likelihood that 
those facilities that do not order consistently will not have medicines and the possibility 
that other facilities could be overstocked whilst another facility in the same area is under 
stocked due to lack of electronic monitoring systems. 
 
An efficient and computerised central purchasing system is highly recommended to 
improve medicine availability in the public sector. Western Cape and North West was 
shown to have above 95% medicine availability. The factors that contributed to this 
include electronic stock management, close monitoring, and weekly reporting on stock 
availability (Pure Health Consulting 2012:129). 
 
The absence of an electronic ordering system which plays a role in effective ordering 
and monitoring of stock was mentioned as a contributory factor in poor medicine 
availability as some facilities would order without any reference, placing orders 
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arbitrarily or based on experience(Strengthening Pharmaceutical Services  2008:39). 
Successful computerisation of medicine supply management has the potential to greatly 
increase an organisation’s efficiency and capability for ensuring consistent medicine 
availability (MSH 2011:50:18). 
 
5.3.5 Duplication of patients 
 
Patients are said to occasionally visit a number of clinics for the same condition without 
allowing the prescribed treatment to take effect. By doing so they attempt to present a 
chronic illness in order to be assessed favourably to qualify for government disability 
grants. Furthermore, due to personal preference for particular health professionals who 
may not be present at the time of the patient’s visit, the patients would come back 
repeatedly and be issued medicine with each visit. The increase in the numbers of 
patients visiting primary health care due to health policy changes post democratic 
government, which classified primary health services as free, and the medicine 
shopping behaviour by the patients visiting more than one facility without allowing the 
original prescription to take effect was reported to also have had a role in the Limpopo 
province’s non-availability of medicine (Baloyi 2009:28). 
 
5.3.6 Medicine theft  
 
There have been few reported incidences of medicine theft in the Free State District 
Health Services. It has been established in Nigeria that a significant proportion of 
essential medicines meant for Primary Health Care are misappropriated or diverted by 
health workers, especially the storekeepers and those at the dispensaries, either for 
personal use or theft (Ohuabunnwa 2008:7). Another confirmation of possible leakages 
and theft of medicines in the health facilities was the acceptance and prevalence of 
inadequate management, security, and controls in KwaZulu-Natal’s Pharmaceutical 
Services leading to increased risk of leakage and theft. The situation is made worse by 
the inadequate availability of experienced pharmacists in the facilities resulting in junior 
personnel, often Community Service Pharmacists, running the pharmacies (KZNDOH 
2012:44). 
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5.3.7 Transportation of medicine across the Free State province  
 
The transportation of medicine in the province is not without challenges as the Medical 
Depot tender for the distribution of medicines has not been finalised. The scope of the 
distribution company is to transport from the Depot to the facilities only, but 
transportation of medicines from one facility to another, as well as outside schedule 
dates for the current contractor for distribution, remains the individual facility’s 
responsibility. This leads to delays as suitable transport for medicine is not available. 
Thus, at time facilities may not have medicine because of lack of transport whilst the 
depot or the neighbouring facility has stock to supply. 
 
Inefficient transport and distribution systems were reported as one of the factors leading 
to frequent stock outs in India (Kotwani et al 2007:652).In a study by Strengthening 
Pharmaceutical Services (2008:37) it was reported that, although there was a delivery 
roster at the depot, the transport of medicine from the depot to the districts and within 
the districts to clinics appeared to be a challenge. In the districts there was no dedicated 
means of transport to deliver medicine from hospitals to clinics. In most instances 
medicines were delivered through patient transport and ambulance or staff’s own 
transport with serious implications on the lead times. 
 
5.3.8 Departmental Red Tape  
 
Facility managers have limited delegations for medicine procurement and the authority 
for approval of orders lies with District Managers and Pharmacists. As a result it takes a 
long time for orders to be finalised. 
 
Furthermore, the requirement of procurement from small-, micro-, and medium 
enterprises expose the department to second level suppliers increasing both the cost of 
and turnaround time for delivery of medicine. The availability could be improved if the 
department could reduce the red tape and long processes by allowing the facility 
managers to authorise orders for medicines at facility level. 
 
In 2008 Kangwana et al (2009:737), in a study conducted to investigate the availability 
of malaria medication in government facilities, found that 25,6% of the surveyed 
facilities did not have any of the four treatment packs in stock. The factors contributing 
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to this stock out were mainly due to procurement failures and delays due to shift from 
direct procurement to open tender processes which was intended to achieve value for 
money and increase competition.  
 
5.4 CONCLUSIONS 
 
The research results demonstrate that there is inadequate availability of medicine in 
district health services due to various factors, including a shortage of pharmacists and 
pharmacists’ assistants in the primary health setting, lack of delegation, red tape in the 
procurement of medicines, and lack of an electronic medicine procurement and 
monitoring system. 
 
5.5 RECOMMENDATIONS FOR IMPROVING MEDICINE AVAILABILITY IN THE 
FREE STATE DISTRICTS’ HEALTH SERVICES 
 
Separate recommendations will be presented for the Free State Department of Health, 
District Health Services and further research. 
 
5.5.1 Recommendations for the Free State Provincial Department of Health  
 
 The Medical Depot and Pharmaceutical Services should be one department 
 
The Free State Department of Health should consider merging the two departments into 
one department for efficiency. 
 
To ensure adequate availability of medicines selection, procurement, use, and 
distribution of medicines should be coordinated seamlessly without breakdown or 
separation(MSH 2011:1:8).This is not the case in the Free State, as Pharmaceutical 
Services and Medical Depot are located in different clusters. The provision of medicine 
in eight of the nine provinces is coordinated by one unit comprising of Pharmaceutical 
Services and the Medical Depot together to promote efficiency and consistent medicine 
availability.  
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 Improve teamwork and communication amongst role players in medicine 
supply 
 
Based on the fact that Pharmaceutical Services, health facilities and the Medical Depot 
are located in various clusters, it is recommended that formal communication forums 
are established and sustained. These include standing multidisciplinary medicine supply 
management meetings, written circulars and memos, as well as teamwork through 
collaboration and secondment of staff during delayed delivery periods to ensure that 
medicine availability information and medicines reach all key stakeholders on time to 
minimise interruptions and stock out in the facilities. 
 
 Invest in an IT system for medicine stock management 
 
The problems of medicine stock management and delays in ordering can be improved 
by the introduction of the electronic medicine supply system to strengthen availability. 
Strengthening Pharmaceutical Services (2008:42) highly recommends the use of 
computerised medicine supply management systems to improve medicine availability.  
 
 Finalisation of distribution transport contract  
 
The distribution transport contract should be finalised so as to ensure consistent 
delivery of medicine to health facilities. Lufesi et al (2007:86) reports that the main 
factors contributing to the medicine shortages are poor deliveries from the Regional 
Medical Store, poor medicine stock management practices and delay in the ordering, as 
well as lack of training and supervision in the facilities and the medical stores. The 
authors recommend that logistical systems should be put in place to ensure continuous 
medicine availability.  
 
 There should be a proper Service Level Agreement with the Medical Depot 
 
The standard delivery periods as well as payment terms and deadlines for medicines 
delivered to the facilities should be documented and agreed on with clear penalties and 
responsibilities between the department health facilities and the Medical Depot to 
improve medicine availability. There should be clear responsibilities and penalties for all 
involved in the provision of medicines, especially the facilities management, who should 
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ensure payment of the medicine account within 30 days to ensure that the depot has 
adequate cash reserves and can pay its suppliers on time. The Medical Depot should 
ensure that stock is available and delivered within a six week period of the placing of the 
order. This can only be achieved once the Service Level Agreement is approved and 
implemented in the province. 
 
 The Medical Depot should keep sufficient stock and buffer stock for all the 
essential and fast moving items to cover for delays in deliveries from the 
suppliers 
 
For consistent availability of medicine the Medical Depot should be able to meet the 
demands of the users at all times. The Medical Depot should keep sufficient stock and 
buffer stock for all the essential and fast moving items to cover for delays in the 
deliveries from the suppliers. The high availability of medicine in Sudan was enhanced 
by the existence of a central medicines store, which is a governmental corporation 
responsible for ensuring that quality medicines are available at affordable prices 
through, amongst others, strategies creation of dedicated funding for medicines and 
implementation of good procurement, storage, transportation, and distribution practices. 
 
In areas where there was less availability of medicine the factors were due to the 
absence of drug (medicine) inventory cards, poor financial support for transportation, 
and distribution from the central medicine store to the pharmacies(Elamin et al 
2010:36). 
 
 There should be regular meetings between the role-players in medicine 
supply, in particular the suppliers  
 
The Medical Depot should also engage the suppliers through standing meetings to 
address any bottlenecks that may occur at times impacting on the medicine stock 
provision. The Medical Depot, facilities, supply chain, and Pharmaceutical Services 
should meet periodically for discussions, updates, and resolution of system red tape 
processes to address the challenges encountered by the facilities in the provision of 
medicines. 
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 The Medical Depot should be enabled to function efficiently 
 
The Department should ensure payment for medicines received within 30 days of 
receipt of invoices to enable the Medical Depot to maintain a healthy cash flow for 
payment of suppliers so that no deliveries are withheld because of non-payment. Lufesi 
et al (2007:86) recommend that logistical systems including, those of the Medical Depot, 
should be put in place to ensure continuous medicine availability. 
 
 Reduce red tape in the procurement of medicines 
 
The province should review the departmental financial delegations to allow authorisation 
of orders at facilities and consider entering into contracts with primary suppliers and 
manufacturers of medicines instead of the procurement of medicines from SMMEs, as 
well as exemption of medicines from the three quotation requirement, as certain 
medicines are only available from one supplier.  
 
5.5.2 Recommendation for the District Health Services  
 
 Make provision for appointment of permanent pharmacists and 
pharmacists’ assistants across the district health services  
 
The province should ensure that there are sufficient posts for appointment of 
pharmacists and pharmacists’ assistants for all levels of care, including primary health 
care and community health centres, to enhance medicine availability and ensure that 
medicine stock ordering and management is not a secondary function of the 
professional nurses who may forget to place orders or rotate stock to prevent expiry of 
medicines. 
 
An investigation on the availability of ARVs and tuberculosis medicines in the South 
African health system reported that the factors contributing to the low availability, 
especially in the clinics setting, were poor stock control and management in nurse-led 
primary health clinics, lack of pharmacists’ assistants to take charge of drug supply 
management. Lack of electronic stock management systems also played a role as the 
manual stock card was found not to be updated in most facilities (Pure Health 
Consulting 2012:97).  
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In another investigation on general medicine shortages the insufficient availability of 
pharmacy personnel in the public health system was also reported  to be amongst the 
contributing factors in the non-availability of medicine in the district health services, as 
nursing personnel tend to prioritise the service delivery and lag behind with consistent 
ordering of replacement medicine stock as well as following up on placed orders for 
uninterrupted supply and availability of medicines (Strengthening Pharmaceutical 
Services 2008:29). 
 
 Establish a Mini Depot in each district  
 
The provision of medicines from one central depot was reported as one of the areas to 
be reviewed as the Free State province’s districts are wide and far apart. The 
recommendation was that there should be a mini depot (warehouse with bulk stock from 
the main depot), at least one in each district, so that the medicine store is closer to the 
facilities, thus reducing the long awaiting delivery period. 
Oakland (2011:71) proposes that the suppliers of goods and services (in our case 
medicine) should be located near service delivery points, delivering frequent small 
quantities to match the service delivery requirements, leading to reduced lead times and 
deliveries being more reliable. 
 
 Managers need to be empowered to effectively and efficiently manage 
medicine stock in the facilities 
 
All facility managers need to be capacitated and trained in budget management and 
medicine supply management and given the necessary delegations to authorise the 
procurement of essential supplies, including medicines, without having to transfer 
documents to the district management to improve lead times for orders processing. The 
capacity building for health facilities management will have an impact on effective 
management of medicines (Strengthening Pharmaceutical Services 2008:43).The 
capacity building could be provided by the partners including Management Sciences for 
Health.  
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5.5.3 Recommendations for further research 
 
Further research should be conducted on the following:  
 
 Strategies to improve medicine availability in district health services. 
 Other provincial district health services on the factors affecting medicine 
availability.  
 
5.6 CONTRIBUTION OF THE STUDY  
 
This study contributes to the field by exposing the factors affecting medicine availability 
in district health services and enabling the district pharmacists and managers to reflect 
on their role in the provision of medicines and make recommendations for improving 
medicine availability. The consistent availability of medicines is a non-negotiable service 
delivery imperative for the South African Department of Health and a vital standard for 
certification and accreditation for National Health Insurance of health establishments by 
the Office of Health Standards Compliance. The study is also the first of its kind to 
explore the whole provincial situation on medicine availability in the South African 
context.  
 
5.7 LIMITATION OF THE STUDY  
 
The study was conducted in one province in South Africa and reflects the findings in the 
context of the Free State. 
 
It is up to the reader of this report to attach meaning and understanding of factors 
affecting medicine availability taking into account their own context as other provincial 
situations may be different. Further study should be conducted in the other provincial 
district health services context to explore the factors affecting medicine availability 
nationally. 
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5.8 CONCLUDING REMARKS  
 
The findings of this study has demonstrated that medicine availability is not in line with 
National Drug policy definitions requiring consistent availability of essential medicines, 
including HIV and AIDS medication, tuberculosis medication, vaccines, and chronic 
conditions medicines.  
 
The non-availability of medicine contributes to poor service user satisfaction and patient 
disease complications, thus reducing life expectancy for the communities. It is therefore 
advisable that the provision of medicines should be improved through recommendations 
from this study, including the deployment of pharmacists and pharmacists’ assistants to 
district health services facilities and also empowerment managers for effective and 
efficient management of medicine supplies.   
  
103 
REFERENCES 
 
Babar, ZU, Ibrahim, MIM, Sing, H & Bukhari, NI. 2005. A survey of medicine prices 
availability, affordability and price components in Malaysia using WHO/HAI 
methodology. University College Sedaya International and University SAINS: Malaysia.  
 
Baloyi, LF. 2009. Problems in providing primary healthcare services: Limpopo province . 
Unpublished Masters Dissertation. Pretoria: Unisa.  
 
Barbie, E. 2010. The practice of social research. 12thedition. USA: Belmont Wadsworth.  
 
Blaxter, L Hughes, C & Tight, M. 2010.How to research. 4th edition. New York: McGraw-
Hill.  
 
Batangan, DB & Juban, N. 2009. Philippines pharmaceutical situation 2009 WHO health 
facility survey on medicines. World Health Organization: West Pacific Region  
 
Bloom, J. 2012 .Medicine shortages continue in Gauteng. Statement issued by Jack 
Bloom MPL, DA Gauteng Health Spokesman, May 15 2012. 
 
Bowling, A. 2009. Research methods in health: investigating health and health services 
England. 3rd edition. Berkshire: Open University Press.  
 
Burns, N & Grove, SK. 2005. The practice of nursing research: conduct, critique and 
utilization. 5th edition. St Louis: Elsevier /Saunders.  
 
Cameroon, A. Ewen, M, Auton, M & Abegunde, D.The world medicine situation 2011. 
Geneva: World Health Organization.  
 
A Cameron, M Ewen, D Ross-Degnan, D Ball, R Laing.2008. Medicine prices, 
availability, and affordability in 36 developing and middle-income countries: a secondary 
analysis.Geneva: World Health Organization. 
 
Cameroon, A, Roubos, I, Ewen, M, Teeuwisse, AK, Leufkens, HGM & Laing, RO. 2011. 
Differences in the availability of medicines for chronic and acute conditions in the public 
and private sectors of developing countries. Bulletin World Health Organization 
(89):412–421.  
 
Cresswell, J.W. 2013. Qualitative inquiry and research design. 3rd edition. Los Angeles: 
SAGE.  
 
Corbin, J & Strauss, A. 2008. Basics of qualitative research. 3rd edition. Thousand 
Oakes: SAGE.  
 
Daniel, G. Tegegnenwork, H, Demissie, T & Reithinger, R. 2011. Pilot assessment of 
supply chains for pharmaceuticals and medical commodities for malaria, tuberculosis 
and HIV infection in Ethiopia. Journal of Transactions of the Royal Society of  Tropical 
Medicine and Hygiene 106(1):60-62.  
From: http://www. ncbi. nlm. nih. gov/pubmed/22093812 (accessed 28 July 2012). 
 
  
104 
De Vos, A.S, Strydom, H, Fouché, CD & Delport, CSL. 2005. Research at grass roots: 
for the social sciences and human service professions. 3rd edition. Pretoria: Van Schaik.  
 
Elamin, IE, Ibrahim, MIM & Yousif, MIM. 2010. Availability of essential medicines in 
Sudan. Sudanese Journal of Public Health 5(1):32-37.  
 
Free State Department of Health. 2012a. Availability of ARV and TB medicines in the 
Free State. Bloemfontein: Free State. Republic of South Africa.  
 
Free State Department of Health. 2012b. Annual Report 2011/2012. Bloemfontein: Free 
State. Republic of South Africa.  
 
Free State Department of Health. 2010. Strategic plan 2010-2014. Bloemfontein: Free 
State Republic of South Africa.  
 
Free State Department of Health. 2009. April medicine availability report. Bloemfontein: 
Free State Republic of South Africa.  
 
Free State Provincial Government 2012: Annual Report for 2012 Bloemfontein: Free 
State Republic of South Africa.  
 
Fokazi, S. Drug shortages spark desperation. Cape Argus. 12July 2012.  From: 
http://www. iol. co. za/news/south-africa/western-cape/drug-shortage-sparks-
desperation-1. 1339871 (accessed 13July 2012).  
 
Gray,A & Manasse, HR (Jr). 2012. Shortages of medicines: a complex global challenge, 
World Health Organization. Bulletin of the World Health Organization 90(3)158-158.  
 
Gray, A, Vawda, Y & Jack, C. 2011.South African health review. Durban: Health System 
Trust. 
 
Gauteng Department of Health 2011. Department of health annual report 2011/2012. 
Johannesburg: Gauteng Republic of South Africa.  
 
GCIS. 2010. Delivery agreement for outcome 2: a long and healthy life for all south 
Africans. Pretoria: Government Printers.  
 
Gavin, R. Irlam, J & Levin, J. 2004. National primary healthcare survey 2003. Durban: 
Health System Trust.  
 
Health24. 2010. Drug shortages in south Africa. :http://www. health24. com/news/Health 
care/1-918, 56153. asp (accessed: 12 May 2010).  
 
Health Systems Trust. 2013. National health facilities baseline audit 2011 national 
summary report. Durban: Health Systems Trust.  
 
 
International Council of Nurses 2011. Closing the gap increasing access and equity. 
Switzerland: ICN.  
 
 
  
105 
Kangwana, BB, Njogu, J, Wasunna, B, Kedenge, SV, Memusi, DN, Goodman, CA. 
Zurovac, D & Snow, RW. 2009. Short report: malaria drug shortages in kenya:a major 
failure to provide access to effective treatment. American Journal of Tropical  Medicine 
and  Hygiene 80(5):737–738.  
 
Kotwani, A, Ewen, M, Dey, D, Lyer, I, Lakshmi, PK., Patel, A, Raman, K, Singhai, GL, 
Thawani, V, Tripathi, S & Laing, R. 200. Prices and availability of common medicines at 
six sites in India using standard methodology. Indian Journal of Medicine Research 
127:645-654.  
 
KwaZulu-Natal Department of Health. 2011. Annual report 2011/12. Pietermaritzburg: 
KwaZulu-Natal.  
 
Lapan, SD, Quartaroli. MT & Riemer, FJ. 2012. Qualitative research an introduction to 
methods and designs. United States of America: Jossey-Bass.  
 
Larkin, H.2011.Drug shortages may be worst. Hospital Health Network.2011 Feb; 
85(2):28-30, 32. 
 
Lufesi, NN, Andrew & Aursnes, I. 2007. Deficient supplies of drugs for life threatening 
diseases in an African community.BMC Health Services Research 7(86):1-7. 
 
Lu,YE. 2006. A survey of medicine prices, availability and affordability in Shangai, China 
using the WHO/HAI methodology. Department of Health Economics, School of Public 
Health Fudan University Shangai, PR China.  
 
Management Sciences for Health. 2011. Managing drug supply. New York: Kumari 
Press Inc.  
 
Management Sciences for Health. 2010. Report back to Free State health executive 
committee by management sciences for health/strengthening pharmaceutical systems 
(MSH/SPS) on request for assistance.  
 
Marshall, C & Rossman, GB. 2011. Designing qualitative research.5th edition. Thousand 
Oaks, California: SAGE.  
 
Matse, PM. 2006. Factors associated with drug shortages in Phc facilities in the Mopani 
district of the Limpopo Province.Unpublished Master Dissertation. Johannesburg: 
University of Witwatersrand.  
 
Merriam Webster. NA. [ONLINE] http://www. merriam-webster. com/dictionary/medicine 
(accessed: 28 February 2011).  
 
McQuarrie, E. F. 2006. The market research toolbox, a concise guide for beginners, 2nd 
edition. San Francisco: SAGE.  
 
Mouton, J. 2001. How to succeed in your master’s and doctoral studies: a South African 
guide and resource book. Pretoria: Van Schaik.  
 
Medicines Sans Frontiers, Treatment Action Campaign, Section 27 and Rural Health 
Advocacy Project 2013. Emergency intervention at Mthatha depot: the hidden cost of 
inaction: Mthatha. Eastern Cape Republic of South Africa.  
  
106 
 
Nash, K. 2012. In short supply. United States of America: Dermatology Times.  
 
National Department of Health (Republic) South Africa. 2012a.Non negotiables for 
Public Health Sector. Pretoria: NDOH.  
 
National Department of Health (Republic) South Africa. 2012b.Annual report 2011/2012. 
Pretoria: NDOH.  
 
National Department of Health (Republic) South Africa. 2011a.Annual report 2010/2011. 
Pretoria: NDOH.  
 
National Department of Health (Republic) South Africa. 2011b. National core standards 
for health establishments in South Africa. Pretoria: NDOH. 
 
National Department of Health (Republic) South Africa. 2009a. Strategic plan 2009 -
2014 Pretoria: Government Printers.  
 
National Department of Health (Republic) South Africa. 2009b. Health programme of 
action. Pretoria: Government Printers.  
 
National Department of Health (Republic) South Africa. 2008. Standard treatment 
guidelines and essential medicines list for South Africa. Pretoria: Government Printers.  
 
(Republic) South Africa. 1996. National drug policy. Pretoria: Government Printers.  
 
Neuman, WL. 2011. Social research methods: qualitative and quantitative approaches. 
7th edition. Boston: Allyn and Bacon.   
 
Oxford South African Concise Dictionary 2007.Oxford University Press. Southern Africa: 
Cape Town. 
 
Oxford Advanced Learner’s Dictionary. 7th edition. 2005. Oxford: Oxford University.  
 
Ohuabunnwa, MSI. 2010. The challenges of making quality essential drugs and supply 
available for PHC Services in Nigeria. World Health Organization Publication 
http://apps. who. int/medicinedocs/documents/s18398en/s18398en. pdf (accessed 13 
June 2012).  
 
Oakland, JS. 2011. Tqm text with cases. 3rd edition. Burlington: Elsevier. 
 
Patel, A, Thawani, V & Gharpure, K. 2005. Medicine pricing, availability and affordability 
report of four regions, maharashtra. India Clinical Epidemiology Unit Indira Gandhi 
Government Medical College, Nagpur: India. From:  http://apps. who. 
int/medicinedocs/documents/s18025en/s18025en. pdf (accessed 28 July 2012).  
 
Padarath, A & English, R (ed) .2013. South African Health Review 2012/13. Durban: 
Health Systems Trust.  
 
Polit, DF & Beck, CT. 2004. Nursing research; principles and methods.7th edition. 
Philadelphia: Lippincott.  
  
107 
 
Public Service Commission. 2011.Citizens talk: a citizen satisfaction survey report . 
Johannesburg. South Africa.  
 
Pure Health Consulting. 2012. Pharmaceutical management of TB in South Africa; rapid 
assessment conducted in 7 provinces.Systems for Improved Access to Pharmaceuticals 
and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health.  
 
QSRI.2008.XSight Data Analysis Software. From:http//www.qsrinternational. 
Com/products xsight. aspx (accessed :03 JANUARY 2012).  
 
Rice, PL & Ezzy, D. 1999. Qualitative research methods a health focus. Singapore: 
Oxford University Press.  
 
SADC. 2007. SADC pharmaceutical business plan 2007-2013. SADC Secretariat June 
2007.  
 
South African Press Association. 2012.Aids drug shortages in six provinces. From: 
http://www. sowetanlive. co. za/news/2012/05/30/aids-drug-shortage-in-6-provinces 
(accessed 05 June 2012)  
 
Schensul, JJ & Le Compte, MD. 2013. Essential ethnographic data collection methods 
:a mixed methods approach. United States of America: Altamira Press.  
 
SECTION 27. 2013. Monitoring our health: an analysis of the breakdown of healthcare 
services in selected Gauteng facilities. South Africa: SECTION 27.  
 
South Africa. 2003. National Health Act, no. 61. 2003. Pretoria: Government Printer.  
 
South Africa. 2002. Medicine and related substance act no. 1965 as amended. Pretoria: 
Government Printers.  
 
South Africa. 1997. Transformation of the public service. Pretoria: Government Printers.  
 
South African Pharmacy Council. 2010. Good Pharmacy Practice in South Africa. 4th 
edition. Arcadia: SAPC.  
 
Strengthening Pharmaceutical Services. 2008: Report on the state of availability and 
delivery of pharmaceuticals in the Northern Cape province.Pretoria: Strengthening 
Pharmaceutical Systems/Management Sciences for Health.  
 
Streubert, HJ & Carpenter, DR. 2011. Qualitative research in nursing–advancing the 
humanistic imperative. 5th edition. Philadephia: Lippincott Williams and Wilkins.  
 
The Survey Workshop. 2010. Patient satisfaction survey in provincial health care 
facilities: Free State. Bloemfontein.  
 
The Survey Workshop. 2012. Patient satisfaction survey in provincial health care 
facilities. Bloemfontein. Free State.  
 
Thom, A & Langa, L. 2010. National medicine shortages. The Star, 12 April:7.  
 
  
108 
Thom, A. 2010. TAC confirms ARV stock –outs. The Star, 12 April:7.  
 
Terre Blanche, M, Durrheim, K & Painter, D (eds). 2006. Research in practice: applied 
methods for the social sciences. 2nd edition. Cape Town: UCT.  
 
Tumwine, Y, Kutyabami, P, Odoi, RA & Kalyango, JN. 2010. Availability and expiry of 
essential medicines and supplies during the ‘pull’ and ‘push’ drug acquisition systems in 
a rural Ugandan Hospital. Tropical Journal of Pharmaceutical Research 9(6):557-564.  
 
United Nations. 2011.Millennium development goal 8: the global partnership for 
development: making rhetoric a reality. MDG Gap Task Force Report 2012. United 
Nations Publications.  
 
Welman, JC, Kruger, F & Mitchell, B. 2005. Research methodology. 3rdedition. Oxford 
University Press: Southern Africa.  
 
Wirtz, VJ, Russo, G & Escobar, ML. 2009. Access to medicines by ambulatory health 
service users in Mexico: an analysis of the national health surveys 1994 to 2006. Salud 
Publica Mex 52:30-38.  
 
White, P. 2009. Developing research questions, a guide for social scientists. 
Hampshire: Palgrave Macmillan.  
 
Wimmer, RD & Dominick, JR. 2006. Mass media research an introduction. 8th edition. 
Belmont: Thomson Wadsworth.  
 
World Health Organization. 2011a. World medicine situation 2011: medicine prices, 
availability and affordability. Geneva: WHO.  
 
World Health Organization. 2011b. Discussion paper essential medicine for non-
communicable diseases. Geneva: WHO  
 
World Health Organization. 2010. Fact Sheet No 325 on Essential Medicines. From: 
http://www. who. int/mediacentre/factsheets/fs325/en/ (accessed 25 June 2012).  
 
World Health Organization. 2007. The availability and affordability of selected essential 
medicines for chronic diseases in six low- and middle-income countries. From: 
http://www.who.int/bulletin/volumes/85/4/06-033647/en/ (accessed 25 June 2012). 
 
WHOAFRICA. 2006. Final report regional workshop on improving procurement and 
supply management systems in the African region, Brazzaville, Congo 2006 June 20-
23.  
 
Yang, H, Dib, HH, Zhu, M, Gang, Q & Zhang, X. 2010.Prices, availability and 
affordability of essential medicines in rural areas of Hubei Province, China. Health 
Policy and Planning 25:219-229.  
 
